https://curecurrent.com/trials/a-trial-investigating-the-effects-of-semaglutide-on-ss-cell-function-in-subjects-with-type-2-diabetes-19001https://curecurrent.com/trials/does-vitamin-d-reduce-risk-of-developing-type-ii-dm-in-high-risk-individuals-19002https://curecurrent.com/trials/the-safety-and-efficacy-of-administrating-diapep277-vaccination-in-type-1-diabetes-patients-19003https://curecurrent.com/trials/turkish-nationwide-survey-of-glycemic-and-other-metabolic-parameters-of-patients-with-diabetes-mellitus-19004https://curecurrent.com/trials/study-looking-at-cardiovascular-effects-of-exenatide-its-blood-pressure-lowering-effect-and-its-mechanisms-19005https://curecurrent.com/trials/evaluation-of-a-cash-transfer-program-in-low-income-families-in-guinea-bissau-19006https://curecurrent.com/trials/validation-of-an-integrated-attention-model-for-patients-with-type-2-diabetes-19007https://curecurrent.com/trials/high-intensity-exercise-and-endothelial-function-in-type-1-diabetes-hiit-t1d-19008https://curecurrent.com/trials/the-artificial-saliva-spray-reduces-xerostomia-in-diabetes-type-ii-19009https://curecurrent.com/trials/the-efficacy-of-group-therapy-in-ultra-orthodox-jewish-young-men-diagnosed-with-type-one-diabetes-19010https://curecurrent.com/trials/cut-down-on-carbohydrate-usage-in-the-diet-of-type-2-diabetes-mechanisms-of-effective-therapy-of-diabetes-by-selective-c-19011https://curecurrent.com/trials/multicenter-clinical-study-of-anti-vegf-treatment-on-high-risk-diabetic-retinopathy-dr-19012https://curecurrent.com/trials/cut-down-on-carbohydrate-usage-in-the-diet-of-type-2-diabetes-19013https://curecurrent.com/trials/the-effect-of-cocoa-flavanol-on-the-bold-response-and-cognitive-function-in-type-1-diabetes-19014https://curecurrent.com/trials/improve-detection-and-management-of-gestational-diabetes-through-the-primary-health-care-level-in-morocco-19015https://curecurrent.com/trials/basal-bolus-vs-sliding-scale-for-treatment-of-diabetic-patients-in-medical-wards-19016https://curecurrent.com/trials/prevalence-of-drp-and-dme-among-type-1-diabetics-treated-with-long-term-intensified-insulin-therapy-19017https://curecurrent.com/trials/use-of-an-automated-insulin-delivery-system-compared-to-sensor-augmented-pump-at-patients-with-type-1-diabetes-t1d-19018https://curecurrent.com/trials/reflexology-and-quality-of-life-19019https://curecurrent.com/trials/qt-interval-abnormalities-in-sulfonylurea-treated-type-2-diabetes-relationship-to-treatment-induced-hypoglycaemia-19020https://curecurrent.com/trials/the-effect-of-daily-consumption-of-extra-virgin-olive-oil-on-blood-glucose-among-diabetic-patients-19021https://curecurrent.com/trials/the-effects-of-vitamin-d-supplementation-on-patients-with-type-2-diabetes-and-vitamin-d-deficiency-19022https://curecurrent.com/trials/extracorporeal-low-intensity-shockwave-in-diabetic-nephropathy-19023https://curecurrent.com/trials/dapagliflozin-cardio-metabolic-risk-factors-and-type-2-diabetes-19024https://curecurrent.com/trials/a-randomised-proof-of-principle-trial-investigating-pharmacodynamics-pharmacokinetics-and-safety-of-nnc0143-0406-in-subj-19025https://curecurrent.com/trials/pharmacokinetics-and-safety-of-evogliptin-in-subjects-with-hepatic-dysfunction-19026https://curecurrent.com/trials/periodontal-treatment-with-diode-laser-in-the-patients-with-diabetes-melitus-19027https://curecurrent.com/trials/trial-to-evaluate-the-efficacy-and-safety-of-gemigliptin-compared-with-placebo-added-on-insulin-alone-or-on-insulin-in-c-19028https://curecurrent.com/trials/effect-of-diabetes-mellitus-on-spinal-block-criteria-during-cesarean-section-19029https://curecurrent.com/trials/nutrition-and-lifestyle-study-cohort-of-gastric-cancer-in-china-19030https://curecurrent.com/trials/nutrition-and-lifestyle-study-cohort-of-colorectal-cancer-in-china-19031https://curecurrent.com/trials/an-open-label-randomized-crossover-study-of-comparative-pharmacokinetics-and-bioequivalence-of-dapagliflozin-metformin-1-19032https://curecurrent.com/trials/hyposalivation-response-to-transcutaneous-electrical-nerve-stimulation-in-diabetic-type-2-patients-19033https://curecurrent.com/trials/shiga-microalbuminuria-reduction-trial-2-19034https://curecurrent.com/trials/benefit-risk-evaluation-of-insuman-implantable-versus-insuplant-using-medtronic-minimed-implantable-pump-system-in-patie-19035https://curecurrent.com/trials/gelesis-glycemic-index-study-19036https://curecurrent.com/trials/the-effect-of-sodium-glucose-cotransporter-2-inhibitors-on-advanced-glycation-end-products-19037https://curecurrent.com/trials/evaluation-of-a-hand-held-fluorescence-digital-imaging-device-for-real-time-advanced-wound-care-monitoring-jdrtc-uhn-19038https://curecurrent.com/trials/preliminary-evaluation-of-pharmacological-lowering-of-ages-19039https://curecurrent.com/trials/pre-point-early-study-19040https://curecurrent.com/trials/evaluation-of-fluorescence-image-guided-wound-assessment-vs-standard-practice-19041https://curecurrent.com/trials/high-intensity-training-self-monitoring-and-diabetes-2-19042https://curecurrent.com/trials/evaluating-the-safety-and-effectiveness-of-liraglutide-in-subjects-with-type-2-diabetes-19043https://curecurrent.com/trials/study-to-promote-weight-loss-in-primary-care-practices-19044https://curecurrent.com/trials/detection-and-treatment-of-somatic-disease-in-patients-with-severe-mental-disease-19045https://curecurrent.com/trials/glucose-absorption-and-gut-hormone-secretion-after-gastric-bypass-19046https://curecurrent.com/trials/effect-of-metformin-on-disease-progression-in-patients-with-cryptogenic-cirrhosis-nash-related-cirrhosis-with-diabetes-o-19047https://curecurrent.com/trials/a-comparative-trial-focusing-on-injections-with-the-medical-device-dv3316-pen-injector-versus-flexpen-19048https://curecurrent.com/trials/psychosocial-factors-related-to-compliance-with-treatment-with-biphasic-insulin-analogues-19049https://curecurrent.com/trials/safety-evaluation-of-adverse-reactions-in-diabetes-19050https://curecurrent.com/trials/efficacy-and-safety-of-liraglutide-in-combination-with-insulin-therapy-compared-to-insulin-alone-in-japanese-subjects-wi-19051https://curecurrent.com/trials/dietary-calcium-supplementation-gut-permeability-and-microbiota-in-type-2-diabetics-19052https://curecurrent.com/trials/pregnancy-outcomes-and-medical-costs-according-to-gestational-diabetes-mellitus-diagnostic-criteria-19053https://curecurrent.com/trials/dietary-intervention-modifies-gut-microbiota-in-type-2-diabetes-19054https://curecurrent.com/trials/effects-of-dapagliflozin-10-mg-on-insulin-resistance-in-patients-with-type-2-diabetes-mellitus-19055https://curecurrent.com/trials/a-comparative-study-of-the-effects-of-qs-m-needle-free-injector-and-glargine-pen-subcutaneous-injection-of-insulin-glarg-19056https://curecurrent.com/trials/psychosocial-issues-in-insulin-pump-therapy-in-children-with-type-1-diabetes-mellitus-dm-19057https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-saxagliptin-in-combination-with-metformin-ir-compared-to-saxagliptin-monotherapy-and-19058https://curecurrent.com/trials/the-hdl-particle-protection-study-19059https://curecurrent.com/trials/quantification-of-cardiovascular-autonomic-neuropathy-can-and-the-effects-of-anaesthesia-on-haemodynamics-and-cerebral-p-19060https://curecurrent.com/trials/improving-adherence-and-commitment-to-treatment-in-diabetic-patients-19061https://curecurrent.com/trials/renal-denervation-in-patients-with-type-2-diabetes-mellitus-19062https://curecurrent.com/trials/normal-versus-dual-wave-insulin-bolus-for-high-protein-food-19063https://curecurrent.com/trials/association-between-trimethylamine-n-oxide-and-gestational-diabetes-mellitus-19064https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-artificial-pancreas-for-5-days-in-adults-with-type-1-diabetes-19065https://curecurrent.com/trials/effect-of-e-balance-pro-therapy-on-diabetes-and-related-complications-19066https://curecurrent.com/trials/the-assessment-of-single-dose-safety-tolerability-pharmacokinetics-and-pharmacodynamic-of-globalagliatin-hydrochloride-19067https://curecurrent.com/trials/clinical-evaluation-of-fenfuro-fenugreek-seed-extract-in-type-2-diabetic-subjects-an-add-on-study-19068https://curecurrent.com/trials/gastric-tolerability-and-pharmacokinetics-of-dmmet-01-19069https://curecurrent.com/trials/metformin-glycinate-on-metabolic-control-and-inflammatory-mediators-in-type-2-diabetes-19070https://curecurrent.com/trials/mmppc-outpatient-clinical-protocol-2016-19071https://curecurrent.com/trials/11c-5-hydroxy-tryptophan-pet-for-assessment-of-islet-mass-in-type-2-diabetes-19072https://curecurrent.com/trials/metformin-to-reduce-heart-failure-after-myocardial-infarction-19073https://curecurrent.com/trials/efficacy-study-of-metformin-glycinate-on-postprandial-lipemia-19074https://curecurrent.com/trials/surgical-offloading-procedures-for-diabetic-foot-ulcers-19075https://curecurrent.com/trials/cardiovascular-oscillations-in-coronary-patients-with-and-without-type-2-diabetes-19076https://curecurrent.com/trials/efficacy-of-different-doses-of-amino-acids-in-5aa-crpic-water-on-glucose-homeostasis-in-a-healthy-population-19077https://curecurrent.com/trials/influence-of-diabetes-on-lower-limb-amputation-19078https://curecurrent.com/trials/could-single-anastomosis-gastric-bypass-be-a-curative-treatment-for-type-ii-diabetes-19079https://curecurrent.com/trials/satisfaction-of-hospitalized-diabetic-patients-using-a-continuous-glucose-monitoring-system-19080https://curecurrent.com/trials/factors-influencing-the-positive-outcome-of-bariatric-surgery-for-morbidly-obese-patients-19081https://curecurrent.com/trials/hypoglycemic-efficacy-of-greenyn-momordica-charantia-extracts-in-diabetic-subjects-19082https://curecurrent.com/trials/effect-of-green-tea-extract-on-arterial-stiffness-in-type-2-diabetes-mellitus-19083https://curecurrent.com/trials/taurine-supplementation-on-cognitive-function-in-patients-with-diabetes-19084https://curecurrent.com/trials/empagliflozin-versus-placebo-on-the-rate-of-arrhythmic-events-in-heart-failure-patients-19085https://curecurrent.com/trials/effect-of-sitagliptin-on-progression-of-coronary-intermediate-lesion-19086https://curecurrent.com/trials/project-plant-protein-the-p3-study-in-humans-19087https://curecurrent.com/trials/taurine-supplementation-on-lower-extremity-vasculopathy-in-patients-with-diabetes-19088https://curecurrent.com/trials/real-time-continuous-glucose-monitoring-in-diabetic-cardiothoracic-surgery-patients-19089https://curecurrent.com/trials/preventing-cardiovascular-ischemic-events-and-arresting-their-consequences-in-type-2-diabetic-population-19090https://curecurrent.com/trials/effect-of-dosing-time-and-meal-on-in-105-insulin-tregopil-pk-and-pd-19091https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-oral-insulin-in-105-in-type-1-diabetes-patients-19092https://curecurrent.com/trials/study-of-the-efficacy-and-tolerance-of-oral-treatment-with-a-total-freeze-dried-culture-of-lcr-restituo-sachets-lactobac-19093https://curecurrent.com/trials/sleep-apnea-and-gestational-diabetes-19094https://curecurrent.com/trials/serum-endostatin-type-2-diabetic-patients-19095https://curecurrent.com/trials/feasibility-study-to-evaluate-the-hybrid-logic-closed-loop-system-in-type-1-diabetes-19096https://curecurrent.com/trials/sitagliptin-in-the-elderly-19097https://curecurrent.com/trials/effect-of-gluconorm-vs-glyburide-on-post-prandial-hyperglycemia-in-elderly-subjects-with-type-2-diabetes-19098https://curecurrent.com/trials/the-effect-of-a-diabetes-action-team-in-patients-post-infrainguinal-bypass-surgery-with-and-without-diabetes-19099https://curecurrent.com/trials/optimizing-insulin-absorption-and-insulin-injection-technique-in-older-adults-19100https://curecurrent.com/trials/healthy-eating-and-active-living-for-diabetes-gestational-diabetes-mellitus-19101https://curecurrent.com/trials/effects-of-sglt2-inhibitor-in-diabetic-patients-with-coronary-artery-disease-19102https://curecurrent.com/trials/new-generation-enlite-accuracy-study-19103https://curecurrent.com/trials/vitamin-d-supplementation-on-metabolic-syndrome-indicators-among-older-adults-alborz-province-iran-19104https://curecurrent.com/trials/the-effect-of-uric-acid-lowering-in-type-1-diabetes-19105https://curecurrent.com/trials/evaluation-of-metabolic-predictors-of-influenza-vaccine-immune-response-in-the-singapore-elderly-population-the-dynamic-19106https://curecurrent.com/trials/children-and-adolescent-registry-for-diabetes-study-in-jiangxi-19107https://curecurrent.com/trials/a-lifestyle-intervention-for-type-2-diabetes-patients-in-kuwait-and-its-impact-on-glycaemic-control-19108https://curecurrent.com/trials/a-trial-investigating-the-effect-of-acute-hypoglycaemia-on-cognitive-function-and-brain-activation-patterns-in-subjects-19109https://curecurrent.com/trials/effects-of-linagliptin-on-renal-endothelium-function-in-patients-with-type-2-diabetes-19110https://curecurrent.com/trials/observational-study-of-safety-and-effectiveness-of-novomix-30-for-the-treatment-of-diabetes-19111https://curecurrent.com/trials/a-study-of-the-effectiveness-of-xultophy-insulin-degludec-liraglutide-in-an-adult-real-world-population-with-type-2-diab-19112https://curecurrent.com/trials/blade-pci-trial-blade-phase-iib-liposomal-alendronate-study-19113https://curecurrent.com/trials/effect-of-protein-hydrolysates-on-hba1c-levels-in-pre-diabetics-19114https://curecurrent.com/trials/insulin-therapy-and-falls-due-to-orthostatic-hypotension-19115https://curecurrent.com/trials/a-follow-up-study-to-evaluate-the-safety-of-allo-asc-dfu-in-allo-asc-dfu-101-clinical-trial-19116https://curecurrent.com/trials/a-trial-to-investigate-the-dose-linearity-of-biochaperone-combo-75-25-and-the-safety-at-three-different-doses-in-subject-19117https://curecurrent.com/trials/qatar-cardiometabolic-registry-19118https://curecurrent.com/trials/soluble-dietary-fibres-in-the-prevention-of-type-2-diabetes-mellitus-19119https://curecurrent.com/trials/vitamin-d-in-diabetic-children-19120https://curecurrent.com/trials/a-trial-of-using-sms-reminder-among-diabetic-retinopathy-patients-in-rural-china-19121https://curecurrent.com/trials/effect-of-morning-versus-evening-perindopril-on-blood-pressure-control-in-people-with-type-2-diabetes-19122https://curecurrent.com/trials/exercise-study-on-cardiac-function-in-patients-with-diabetes-mellitus-type-2-and-diastolic-dysfunction-19123https://curecurrent.com/trials/effectiveness-of-proprioceptive-training-on-plantar-pressure-balance-posture-and-gait-in-individuals-with-diabetes-melli-19124https://curecurrent.com/trials/quantification-of-proteomes-l-plastin-lipocalin-and-adiponectin-in-chronic-periodontitis-and-diabetic-subjects-19125https://curecurrent.com/trials/52-week-trial-of-liraglutide-in-type-1-diabetes-19126https://curecurrent.com/trials/prevalence-of-drp-and-dme-among-type-1-diabetics-treated-with-long-term-intensified-insulin-therapy-19127https://curecurrent.com/trials/copeptin-testing-during-pre-hospital-care-in-the-treatment-of-chest-pain-suggestive-of-acute-coronary-syndrome-19128https://curecurrent.com/trials/angiotensin-ii-blockade-and-inflammation-in-obesity-19129https://curecurrent.com/trials/association-between-dietary-pattern-and-glycemic-control-among-type-2-diabetes-patients-in-the-unites-arab-emirates-19130https://curecurrent.com/trials/allopurinol-and-endothelial-function-in-diabetic-cad-patients-19131https://curecurrent.com/trials/a-clinical-trial-testing-the-efficacy-of-pdt-in-preventing-amputation-in-diabetic-patients-19132https://curecurrent.com/trials/bi-1356-bs-in-japanese-patients-with-type-2-diabetes-mellitus-19133https://curecurrent.com/trials/non-invasive-validation-of-non-invasive-central-blood-pressure-measurements-using-oscillometric-pulse-wave-analysis-19134https://curecurrent.com/trials/web-based-dietary-intervention-for-diabetic-patients-19135https://curecurrent.com/trials/short-term-effect-of-liraglutide-versus-vildagliptine-on-insulin-secretion-and-insulin-sensitivity-in-type-2-diabetes-19136https://curecurrent.com/trials/early-term-delivery-versus-expectant-management-of-the-large-for-gestational-age-fetus-19137https://curecurrent.com/trials/the-adaptation-usability-and-feasibility-of-a-mobile-health-mhealth-system-to-improve-type-2-diabetes-self-management-in-19138https://curecurrent.com/trials/effects-of-tinzaparin-on-cardio-vascular-outcomes-and-on-blood-lipids-in-diabetic-patients-on-chronic-hemodialysis-19139https://curecurrent.com/trials/comparing-two-different-approaches-in-the-screening-of-cystic-fibrosis-related-diabetes-19140https://curecurrent.com/trials/oxemet-1000-mg-coated-tablets-metformin-hydrochloride-bioequivalence-study-oxemet-tm-is-a-trademark-of-the-glaxosmithkli-19141https://curecurrent.com/trials/fiber-enriched-buckwheat-pasta-and-glucose-variability-in-patients-with-type-1-diabetes-and-celiac-disease-19142https://curecurrent.com/trials/investigating-the-pharmacokinetics-safety-and-tolerability-after-a-single-subcutaneous-injection-of-semaglutide-in-subje-19143https://curecurrent.com/trials/glargine-versus-nph-in-patients-with-chronic-kidney-disease-19144https://curecurrent.com/trials/the-effect-of-gluten-free-diet-in-type-1-diabetics-with-dyspepsia-symptoms-19145https://curecurrent.com/trials/a-trial-investigating-the-effect-of-oral-semaglutide-on-the-pharmacokinetics-of-furosemide-and-rosuvastatin-in-healthy-s-19146https://curecurrent.com/trials/evaluate-the-correlation-of-nirs-abi-exercise-bapwv-and-albuminuria-with-peripheral-artery-occlusion-disease-pad-and-oth-19147https://curecurrent.com/trials/study-of-the-association-of-muscle-strength-balance-and-other-factors-with-vitamin-levels-among-elderly-diabetics-19148https://curecurrent.com/trials/effect-of-probiotics-on-pre-diabetes-and-diabetes-in-china-19149https://curecurrent.com/trials/study-to-understand-usage-and-effect-of-saxagliptin-as-first-add-on-after-metformin-in-indian-type-2-diabetes-mellitus-p-19150https://curecurrent.com/trials/accuracy-of-two-cgm-systems-tested-simultaneously-in-ambulatory-patients-with-type-1-diabetes-19151https://curecurrent.com/trials/safety-and-efficacy-of-liraglutide-in-combination-with-an-oad-in-subjects-with-type-2-diabetes-insufficiently-controlled-19152https://curecurrent.com/trials/metabolic-and-hormonal-effects-of-5-2-intermittent-fasting-19153https://curecurrent.com/trials/implementation-of-foot-thermometry-and-sms-and-voice-messaging-to-prevent-diabetic-foot-ulcer-19154https://curecurrent.com/trials/a-trial-investigating-the-influence-of-oral-semaglutide-on-the-pharmacokinetics-of-levothyroxine-and-the-influence-of-co-19155https://curecurrent.com/trials/analysis-of-changes-in-medication-prescriptions-after-hospitalization-for-4-disciplines-gerontology-diabetology-cardiolo-19156https://curecurrent.com/trials/safety-and-efficacy-of-autologous-bone-marrow-stem-cells-for-lower-extremity-ischemia-treating-19157https://curecurrent.com/trials/reliability-of-a-diabetic-foot-ulcer-risk-stratification-and-referral-algorithm-19158https://curecurrent.com/trials/a-trial-to-investigate-the-safety-and-the-pharmacokinetic-pharmacodynamic-characteristics-of-two-biochaperone-glucagon-f-19159https://curecurrent.com/trials/a-trial-to-evaluate-the-pharmacokinetic-and-pharmacodynamic-properties-of-biochaperone-insulin-lispro-fiasp-and-novorapi-19160https://curecurrent.com/trials/accuracy-satisfaction-and-usability-of-a-fgm-system-among-children-and-adolescents-attending-a-diabetes-summer-camp-19161https://curecurrent.com/trials/caffeine-consumption-and-mortality-in-diabetes-19162https://curecurrent.com/trials/interaction-of-potassium-and-genetic-risk-variants-on-diabetes-risk-19163https://curecurrent.com/trials/a-trial-investigating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-subcutaneous-nnc0123-0338-in-heal-19164https://curecurrent.com/trials/dietary-analyses-in-the-nurses-health-study-nurses-health-study-ii-and-health-professionals-follow-up-study-19165https://curecurrent.com/trials/two-narrative-medicine-interventions-in-type-1-diabetes-19166https://curecurrent.com/trials/bioequivalence-study-of-combination-tablets-of-saxagliptin-dapagliflozin-metformin-xr-extended-release-and-dapagliflozin-19167https://curecurrent.com/trials/evaluation-of-the-retina-of-subjects-without-diabetes-mellitus-and-subjects-with-diabetes-mellitus-without-diabetic-reti-19168https://curecurrent.com/trials/mindfulness-based-arabic-guided-self-help-for-parents-of-children-with-type-1-diabetes-19169https://curecurrent.com/trials/effects-of-resistive-exercise-or-proprioceptive-exercise-training-among-patients-with-type-2-diabetes-mellitus-19170https://curecurrent.com/trials/myocardial-dysfunction-in-type-2-diabetes-mellitus-t2dm-19171https://curecurrent.com/trials/a-trial-investigating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-subcutaneous-nnc0143-0406-a-0-6-m-19172https://curecurrent.com/trials/comprehensive-awareness-and-control-in-diabetes-patients-in-china-jiangxi-a-cross-sectional-survey-19173https://curecurrent.com/trials/characteristics-of-type-2-diabetes-patients-treated-with-insulin-and-their-follow-up-care-in-guadeloupe-19174https://curecurrent.com/trials/intracavernous-injection-of-autologous-mesenchymal-stem-cells-in-the-treatment-of-erectile-dysfunction-resistant-to-oral-19175https://curecurrent.com/trials/pharmacokinetics-of-metformin-intolerance-19176https://curecurrent.com/trials/freestyle-libre-in-pregnancy-study-19177https://curecurrent.com/trials/omarigliptin-trelagliptin-in-twelve-healthy-egyptian-volunteers-19178https://curecurrent.com/trials/trial-investigating-the-effect-of-semaglutide-on-energy-intake-appetite-sensations-postprandial-glucose-and-triglyceride-19179https://curecurrent.com/trials/effect-of-l-citrulline-supplementation-on-arginase-activity-and-vascular-function-in-diabetes-19180https://curecurrent.com/trials/the-effect-of-diabetes-on-the-newborn-19181https://curecurrent.com/trials/betafoam-diabetes-mellitus-foot-study-19182https://curecurrent.com/trials/glucose-dependent-asprosin-dynamics-19183https://curecurrent.com/trials/the-effect-of-combination-of-mosapride-and-dpp-4-inhibitor-on-plasma-concentration-of-incretin-hormones-19184https://curecurrent.com/trials/the-effects-of-premeal-consumption-of-protein-enriched-bar-on-blood-glucose-level-and-secretion-of-hormones-19185https://curecurrent.com/trials/effects-of-a-glp-1-receptor-agonist-on-functional-activation-and-connectivity-of-the-brain-19186https://curecurrent.com/trials/applicability-of-cellular-application-in-diabetes-type-2-patients-19187https://curecurrent.com/trials/evaluation-of-a-diabetes-treatment-and-education-program-for-insulin-pump-therapy-input-19188https://curecurrent.com/trials/golf-and-diabetes-19189https://curecurrent.com/trials/group-versus-individual-care-in-diabetes-clinic-19190https://curecurrent.com/trials/mitochondrial-effects-of-c18-0-supplementation-in-humans-19191https://curecurrent.com/trials/comparing-continuous-subcutaneous-insulin-infusion-with-multiple-daily-injections-to-reach-hba1c-targets-in-children-and-19192https://curecurrent.com/trials/a-comparison-of-measurements-of-ketone-body-flux-versus-ketone-body-concentration-as-a-pharmacodynamic-marker-of-hepatic-19193https://curecurrent.com/trials/can-ultrasound-predict-nerve-injury-following-posterior-tibial-nerve-block-in-patients-with-peripheral-neuropathy-19194https://curecurrent.com/trials/low-fructose-diet-in-diabetes-type-2-19195https://curecurrent.com/trials/development-of-a-molecular-diagnosing-platform-for-monitoring-oral-hygiene-in-diabetic-patients-19196https://curecurrent.com/trials/a-german-study-evaluating-the-efficacy-and-the-benefit-of-integrated-personalized-diabetes-management-pdm-for-type-2-dia-19197https://curecurrent.com/trials/gmvs-in-primary-care-an-rct-of-group-based-versus-individual-appointments-to-reduce-hba1c-in-older-people-19198https://curecurrent.com/trials/the-effect-of-steroids-on-maternal-glucose-levels-19199https://curecurrent.com/trials/liraglutide-and-cardio-metabolic-risk-markers-19200https://curecurrent.com/trials/a-clinical-study-to-evaluate-safety-tolerability-and-pharmacokinetics-of-oral-hms5552-in-healthy-volunteers-19201https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-hms5552-in-patients-with-type-2-diabetes-19202https://curecurrent.com/trials/a-feasibility-study-to-evaluate-the-performance-of-the-harmony-1-sensors-in-adults-and-pediatrics-19203https://curecurrent.com/trials/pancreatic-cancer-can-be-detected-by-adrenomedullin-in-new-onset-diabetes-patients-19204https://curecurrent.com/trials/an-evaluation-of-internet-based-carbohydrate-counting-education-for-adolescents-with-type-1-diabetes-19205https://curecurrent.com/trials/esteem-effect-of-simple-targeted-diet-in-pregnant-women-with-metabolic-risk-factors-on-pregnancy-outcomes-19206https://curecurrent.com/trials/impact-of-self-care-education-program-in-patients-with-type-2-diabetes-in-primary-care-in-the-basque-country-19207https://curecurrent.com/trials/freestyle-libre-effect-on-qol-in-type-2-diabetes-patients-19208https://curecurrent.com/trials/assessment-of-color-vision-in-diabetic-patients-19209https://curecurrent.com/trials/acetylsalicylic-acid-and-type-2-diabetes-mellitus-19210https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-the-benefit-of-integrated-personalized-diabetes-management-pdm-for-diabetic-patients-19211https://curecurrent.com/trials/e-coaching-for-type-2-diabetes-19212https://curecurrent.com/trials/effect-of-two-alcohol-free-beers-with-different-carbohydrates-composition-on-lipids-and-glucose-metabolism-19213https://curecurrent.com/trials/exercise-induced-blood-glucose-response-in-patients-with-type-2-diabetes-19214https://curecurrent.com/trials/drug-drug-interaction-between-simvastatin-and-shr3824-19215https://curecurrent.com/trials/five-year-incidence-of-age-related-macular-degeneration-in-the-central-region-of-portugal-19216https://curecurrent.com/trials/the-effects-of-the-laparoscopic-roux-en-y-gastric-bypass-and-laparoscopic-mini-gastric-bypass-on-the-remission-of-type-i-19217https://curecurrent.com/trials/evaluation-of-long-term-coronary-stenting-outcomes-in-diabetic-patients-with-or-without-optimal-glycemic-control-19218https://curecurrent.com/trials/insulin-pump-vs-multiple-daily-injection-on-cardiovascular-outcomes-italico-19219https://curecurrent.com/trials/a-first-in-human-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-hm12470-19220https://curecurrent.com/trials/the-effect-of-hypocaloric-diet-associated-with-tdcs-on-weight-loss-and-metabolic-profile-19221https://curecurrent.com/trials/long-term-cgm-treatment-in-patients-with-type-1-diabetes-treated-with-insulin-injections-19222https://curecurrent.com/trials/impact-of-different-types-of-exercise-training-on-biochemical-markers-of-insulin-dependent-patients-19223https://curecurrent.com/trials/evaluation-of-quality-of-care-shared-care-programme-ha-19224https://curecurrent.com/trials/does-protein-and-fat-content-of-meal-increase-glucose-concentrations-19225https://curecurrent.com/trials/a-study-to-investigate-the-glucose-lowering-effects-of-dextromethorphan-alone-or-in-combination-with-sitagliptin-in-subj-19226https://curecurrent.com/trials/frequency-of-eye-problems-in-type-2-diabetes-with-chronic-kidney-disease-19227https://curecurrent.com/trials/a-study-of-ly3209590-in-healthy-participants-and-participants-with-type-2-diabetes-19228https://curecurrent.com/trials/closed-loop-with-faster-aspart-in-young-adults-with-type-1-diabetes-19229https://curecurrent.com/trials/d-tecting-disease-from-exposure-to-vitamin-d-during-critical-periods-of-life-19230https://curecurrent.com/trials/telemedicine-on-metabolic-control-in-type-1-diabetes-mellitus-andalusian-patients-platedian-19231https://curecurrent.com/trials/a-clinical-trial-to-investigate-the-pharmacokinetic-drug-interaction-between-yhr1705-and-yhr1706-19232https://curecurrent.com/trials/hope-theory-as-ability-determinant-to-permanently-change-the-adapted-physical-activity-apa-in-type-2-diabetic-patients-19233https://curecurrent.com/trials/the-effect-of-gastric-bypass-surgery-on-diabetes-19234https://curecurrent.com/trials/the-impact-of-patient-complexity-on-healthcare-utilization-19235https://curecurrent.com/trials/the-effect-of-liraglutide-on-body-weight-in-obese-subjects-without-diabetes-19236https://curecurrent.com/trials/diabetes-self-management-education-dsme-and-its-effect-on-clinical-psychosocial-and-behavioral-outcomes-19237https://curecurrent.com/trials/a-study-in-healthy-male-volunteers-to-investigate-different-doses-of-a-new-drug-for-the-treatment-of-metabolic-diseases-19238https://curecurrent.com/trials/closed-loop-control-of-postprandial-glucose-levels-after-meals-with-different-macronutrients-content-in-adults-with-type-19239https://curecurrent.com/trials/effect-of-sitagliptin-on-graft-function-following-islet-transplantation-19240https://curecurrent.com/trials/the-alberta-vascular-risk-reduction-community-pharmacy-project-rxeach-19241https://curecurrent.com/trials/comparison-of-insulin-pump-and-mdi-for-pregestational-diabetes-during-pregnancy-19242https://curecurrent.com/trials/an-observational-study-to-assess-the-canagliflozin-treatment-in-type-2-diabetes-mellitus-in-a-usual-clinical-practice-in-19243https://curecurrent.com/trials/the-effect-of-pharmacological-antilipolysis-on-the-metabolic-effects-of-ghrelin-19244https://curecurrent.com/trials/comparison-of-metformin-and-insulin-for-management-of-gestational-diabetes-mellitus-19245https://curecurrent.com/trials/improving-glucose-and-lipid-metabolism-through-caloric-restriction-using-diet-or-surgery-crudos-19246https://curecurrent.com/trials/impact-of-a-training-in-therapeutic-education-on-the-relation-between-care-givers-and-their-patients-19247https://curecurrent.com/trials/the-phase-ii-study-of-bardoxolone-methyl-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-tsubaki-study-19248https://curecurrent.com/trials/closed-loop-control-of-postprandial-glucose-levels-in-children-and-adults-with-type-1-diabetes-19249https://curecurrent.com/trials/technology-augmented-self-monitoring-model-among-patients-with-type-2-diabetes-and-hypertension-19250https://curecurrent.com/trials/arterial-stiffness-and-complication-risk-in-type-2-diabetes-19251https://curecurrent.com/trials/evaluation-of-quality-of-care-risk-assessment-management-programme-ha-19252https://curecurrent.com/trials/response-to-oral-agents-in-diabetes-road-pilot-study-19253https://curecurrent.com/trials/a-study-of-adding-linagliptin-to-control-glycemic-variability-and-hba1c-in-peritoneal-dialysis-patients-with-type-2-diab-19254https://curecurrent.com/trials/open-label-investigation-of-the-safety-and-effectiveness-of-diabecell-r-in-patients-with-type-i-diabetes-mellitus-19255https://curecurrent.com/trials/safety-and-efficacy-of-alogliptin-in-indian-participants-with-type-2-diabetes-mellitus-19256https://curecurrent.com/trials/the-effects-of-mediterranean-diet-on-remission-lipid-profile-weight-and-body-composition-in-children-and-adolescents-wit-19257https://curecurrent.com/trials/an-exploratory-clinical-trial-to-generate-whole-blood-samples-for-analysing-genetic-polymorphisms-19258https://curecurrent.com/trials/open-label-investigation-of-the-safety-and-effectiveness-of-diabecell-in-patients-with-type-1-diabetes-mellitus-19259https://curecurrent.com/trials/stemi-and-incretins-treatment-19260https://curecurrent.com/trials/continuous-glucose-monitoring-during-intecorse-in-young-adults-with-type-1-diabetes-19261https://curecurrent.com/trials/randomized-crossover-study-to-test-the-impact-of-using-a-software-for-smartphones-and-tablets-in-treating-type-1-diabete-19262https://curecurrent.com/trials/comparative-response-to-vascular-injury-in-patients-with-diabetes-mellitus-an-oct-study-of-bvs-versus-xience-des-19263https://curecurrent.com/trials/teaching-individual-to-increase-adherence-to-therapeutic-regimen-in-hypertension-arterial-and-or-diabetes-type-2-19264https://curecurrent.com/trials/study-of-insulin-pump-in-prevention-of-low-glucose-events-in-adults-with-type-1-diabetes-at-risk-of-severe-hypoglycemia-19265https://curecurrent.com/trials/diabetes-glucose-control-glucose-lowering-medications-and-cancer-risk-a-10-year-population-based-historical-cohort-19266https://curecurrent.com/trials/effects-of-primary-prevention-in-elderly-people-the-healthy-aging-initiative-19267https://curecurrent.com/trials/effect-of-oral-administration-of-a-herbarium-mixture-guazuma-ulmifolia-and-tecoma-stans-on-metabolic-profile-in-type-2-d-19268https://curecurrent.com/trials/supporting-practices-to-adopt-registry-based-care-19269https://curecurrent.com/trials/a-risk-scores-for-predicting-prevalence-of-diabetes-in-the-lao-population-19270https://curecurrent.com/trials/locally-delivered-1-metformin-gel-in-peri-implantitis-19271https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-a-digital-disease-management-tool-in-patients-with-type-2-diabetes-mellitus-19272https://curecurrent.com/trials/an-assessment-of-pharmacokinetic-gemigliptin-and-metformin-interactions-in-healthy-mexican-volunteers-19273https://curecurrent.com/trials/evaluation-of-food-effect-on-the-pharmacokinetics-of-sustained-release-metformin-in-healthy-indian-volunteers-19274https://curecurrent.com/trials/impact-of-a-low-carbohydrate-breakfast-on-glucose-control-in-type-2-diabetes-19275https://curecurrent.com/trials/gestational-diabetes-a-cohort-study-19276https://curecurrent.com/trials/bioflow-iii-hungary-satellite-registry-19277https://curecurrent.com/trials/multiple-ascending-dose-study-of-gmc-252-l-lys-salt-in-healthy-subjects-and-type-2-diabetics-19278https://curecurrent.com/trials/effects-of-genmont-probiotic-on-improve-the-level-of-blood-glucose-and-other-diabetic-associate-parameter-in-type-2-diab-19279https://curecurrent.com/trials/effect-of-breakfast-or-omission-of-breakfast-in-t2d-19280https://curecurrent.com/trials/cardiovascular-effects-of-empagliflozine-19281https://curecurrent.com/trials/tofo-insulin-combination-trial-19282https://curecurrent.com/trials/the-work-of-being-a-patient-with-diabetes-data-collection-via-a-smartphone-application-19283https://curecurrent.com/trials/effects-of-whey-protein-in-type-2-diabetics-19284https://curecurrent.com/trials/pretreatment-identification-of-duloxetine-success-in-neuropathic-pain-patients-19285https://curecurrent.com/trials/the-relationship-between-sleep-and-glucose-tolerance-in-prediabetes-the-role-of-glp-1-in-short-sleepers-19286https://curecurrent.com/trials/comparison-of-the-efficacy-and-tolerability-of-the-addition-of-avandia-to-submaximal-doses-of-metformin-19287https://curecurrent.com/trials/effect-of-cilostazol-on-coronary-artery-stenosis-and-plaque-characteristics-in-patients-with-t2dm-19288https://curecurrent.com/trials/a-trial-evaluating-the-effect-of-nn1250-at-steady-state-conditions-in-subjects-with-type-1-diabetes-19289https://curecurrent.com/trials/efficacy-and-safety-in-poorly-controlled-type-2-diabetics-19290https://curecurrent.com/trials/avandia-with-glyburide-in-african-american-and-hispanic-patients-with-type-2-diabetes-not-controlled-by-glyburide-alone-19291https://curecurrent.com/trials/a-trial-investigating-the-within-subject-variability-of-nn1250-in-subjects-with-type-1-diabetes-19292https://curecurrent.com/trials/continuous-glucose-monitor-in-children-with-poorly-controlled-diabetes-19293https://curecurrent.com/trials/insulin-profile-of-biphasic-insulin-aspart-70-to-that-of-biphasic-insulin-aspart-30-in-healthy-volunteers-19294https://curecurrent.com/trials/effects-of-physical-exercise-in-type-2-diabetics-19295https://curecurrent.com/trials/the-effect-of-transcranial-direct-current-stimulation-t-dcs-on-the-p300-component-of-event-related-potentials-in-patient-19296https://curecurrent.com/trials/the-smart-phone-as-a-physical-fitness-monitor-validity-sensitivity-and-motivation-interwalk-19297https://curecurrent.com/trials/resveratrol-s-effects-in-diabetic-nephropathy-19298https://curecurrent.com/trials/accuracy-of-freestyle-libre-19299https://curecurrent.com/trials/tapestry-with-health-connnectors-for-diabetes-management-19300https://curecurrent.com/trials/dissemination-of-cvd-risk-factor-treatment-among-diabetic-patients-in-safety-net-clinics-19301https://curecurrent.com/trials/effect-of-meal-frequency-on-glycemic-control-of-people-at-high-risk-or-diagnosed-with-diabetes-19302https://curecurrent.com/trials/preschool-cgm-use-and-glucose-variability-in-type-1-diabetes-19303https://curecurrent.com/trials/effect-of-intensive-therapy-associated-with-csii-on-cell-function-with-newly-diagnosed-type-2-diabetes-19304https://curecurrent.com/trials/autologous-bone-marrow-mononuclear-cell-transplantation-in-treating-type-2-diabetes-mellitus-19305https://curecurrent.com/trials/long-term-sulfonylurea-response-in-kcnj11-neonatal-diabetes-19306https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-saxagliptin-added-to-insulin-monotherapy-or-to-insulin-combined-with-metformin-in-ch-19307https://curecurrent.com/trials/comparison-of-exenatide-and-metformin-monotherapy-in-overweight-obese-patients-with-newly-diagnosed-type-2-diabetes-19308https://curecurrent.com/trials/mwellcare-an-integrated-mhealth-system-for-the-prevention-and-care-of-chronic-disease-19309https://curecurrent.com/trials/the-effects-of-barberry-juice-consumption-in-patients-with-type-2-diabetes-19310https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-ertugliflozin-monotherapy-in-the-treatment-of-participants-with-type-2-diabetes-me-19311https://curecurrent.com/trials/bioflow-iii-israel-satellite-registry-19312https://curecurrent.com/trials/evidence-based-lifestyle-prescription-program-pilot-study-19313https://curecurrent.com/trials/bioflow-iii-austria-satellite-registry-19314https://curecurrent.com/trials/bioflow-iii-asia-registry-orsiro-stent-system-19315https://curecurrent.com/trials/bioflow-iii-sweden-satellite-registry-19316https://curecurrent.com/trials/bioflow-iii-belgium-satellite-registry-19317https://curecurrent.com/trials/effectiveness-of-a-case-management-model-for-patients-with-hypertension-and-type-ii-diabetes-in-chile-19318https://curecurrent.com/trials/a-peer-support-program-to-enhance-treatment-adherence-in-patients-with-type-2-dm-19319https://curecurrent.com/trials/the-effects-of-metformin-on-self-selected-exercise-intensity-physical-fitness-and-exercise-induced-ampk-activation-19320https://curecurrent.com/trials/clinical-system-accuracy-evaluation-with-onetouch-verio-flex-blood-glucose-monitoring-system-bgms-19321https://curecurrent.com/trials/innovation-of-breakfast-cereals-and-snacks-for-control-of-appetite-and-post-prandial-glycemia-19322https://curecurrent.com/trials/intervention-to-enhance-numeracy-in-diabetes-intend-19323https://curecurrent.com/trials/pregnancies-and-cystic-fibrosis-19324https://curecurrent.com/trials/prediction-of-inflammatory-response-and-hypotensive-syndrome-after-cardiac-surgery-by-preoperative-copeptin-level-19325https://curecurrent.com/trials/meal-composition-and-the-influence-on-pre-prandial-blood-glucose-values-19326https://curecurrent.com/trials/efficacy-and-safety-of-weekly-subcutaneous-mln1202-in-improving-diabetic-nephropathy-in-participants-with-macroalbuminur-19327https://curecurrent.com/trials/effects-of-low-intensity-therapeutic-ultrasound-on-endothelial-function-19328https://curecurrent.com/trials/social-determinants-in-chronic-disease-in-british-columbia-19329https://curecurrent.com/trials/bone-marrow-mononuclear-cell-and-hyperbaric-oxygen-therapy-in-diabetes-mellitus-19330https://curecurrent.com/trials/prevention-of-hypoglycemia-after-exercise-using-closed-loop-system-in-children-and-adolescents-with-type-1-diabetes-19331https://curecurrent.com/trials/bioflow-iii-canada-satellite-registry-19332https://curecurrent.com/trials/association-between-dietary-habits-and-gestational-diabetes-19333https://curecurrent.com/trials/effect-of-folic-acid-and-vitamin-b12-supplementation-in-subjects-with-type-2-diabetes-19334https://curecurrent.com/trials/evaluation-of-3d-imaging-ulcer-camera-19335https://curecurrent.com/trials/individually-tailored-treatment-of-type-2-diabetes-19336https://curecurrent.com/trials/lifestyle-in-turkish-background-diabetics-19337https://curecurrent.com/trials/the-effect-of-intravenous-lactate-on-brain-lactate-concentrations-during-hypoglycemia-19338https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-drug-drug-interaction-of-evogliptin-5mg-and-glimepiride-4mg-19339https://curecurrent.com/trials/pharmacokinetic-pharmacodynamic-drug-drug-interaction-of-evogliptin-5-mg-and-pioglitazone-30-mg-19340https://curecurrent.com/trials/an-extended-treatment-study-of-mt-3995-in-patients-with-diabetic-nephropathy-19341https://curecurrent.com/trials/multifactorial-control-of-type-2-diabetes-and-treatment-intensity-in-primary-care-19342https://curecurrent.com/trials/doppler-ultrasound-in-early-detection-of-diabetic-nephropathy-type-2-diabetes-mellitus-19343https://curecurrent.com/trials/trial-of-otelixizumab-for-adolescents-and-adults-with-newly-diagnosed-type-1-diabetes-mellitus-autoimmune-defend-2-19344https://curecurrent.com/trials/evaluate-the-value-of-telehomecare-for-diabetes-19345https://curecurrent.com/trials/the-psiqs-study-user-experience-with-pro-set-19346https://curecurrent.com/trials/levothyroxine-for-non-alcoholic-fatty-liver-disease-nafld-19347https://curecurrent.com/trials/insulin-based-strategies-to-prevent-hypoglycemia-during-exercise-19348https://curecurrent.com/trials/muscle-strength-training-for-older-adults-with-type-ii-diabetes-19349https://curecurrent.com/trials/user-performance-evaluation-of-contour-next-one-accu-chek-aviva-connect-freestyle-freedom-lite-onetouch-verio-and-glucom-19350https://curecurrent.com/trials/families-defeating-diabetes-19351https://curecurrent.com/trials/effect-of-oral-appliance-therapy-on-glucose-levels-in-patients-with-t2dm-and-osa-a-pilot-trial-19352https://curecurrent.com/trials/headspace-mindfulness-app-trial-19353https://curecurrent.com/trials/safety-and-efficiency-of-linagliptin-trajenta-in-the-setting-of-internal-medicine-department-19354https://curecurrent.com/trials/a-phase-iii-study-of-bms-512148-dapagliflozin-in-asian-patients-with-type-2-diabetes-who-are-not-well-controlled-on-metf-19355https://curecurrent.com/trials/correlation-between-plasma-and-endothelial-dpp-4-activity-19356https://curecurrent.com/trials/meal-tolerance-trial-in-pregnant-women-diagnosed-with-gestational-diabetes-mellitus-19357https://curecurrent.com/trials/evaluation-of-quality-of-care-patient-empowerment-programme-ha-19358https://curecurrent.com/trials/intra-individual-variability-and-circadian-rhythm-of-vegf-levels-and-interaction-with-biomarkers-19359https://curecurrent.com/trials/transplantlines-insulin-resistance-and-inflammation-biobank-and-cohort-study-19360https://curecurrent.com/trials/non-interventional-post-marketing-surveillance-study-of-xultophy-insulin-degludec-liraglutide-to-evaluate-long-term-safe-19361https://curecurrent.com/trials/assessment-of-service-and-hearing-dogs-19362https://curecurrent.com/trials/control-of-blood-glucose-fluctuation-with-usage-of-polyherbal-19363https://curecurrent.com/trials/vitamin-c-as-an-adjunct-in-periodontal-treatment-in-type-2-diabetes-mellitus-patients-19364https://curecurrent.com/trials/post-marketing-surveillance-special-use-results-surveillance-on-use-with-liraglutide-victoza-19365https://curecurrent.com/trials/clinical-study-to-evaluate-efficacy-and-safety-of-allo-asc-dfu-in-patients-with-diabetic-foot-ulcers-19366https://curecurrent.com/trials/the-sorbact-antimicrobial-dressing-in-the-holistic-wound-management-of-diabetic-foot-ulcers-phase-iii-study-19367https://curecurrent.com/trials/the-association-between-diabetes-mellitus-oral-lichen-planus-and-insulin-like-growth-factors-1-and-2-igf1-and-igf2-19368https://curecurrent.com/trials/sodium-glucose-co-transporter-2-sglt2-inhibitor-risk-of-below-knee-lower-extremity-amputation-a-retrospective-cohort-stu-19369https://curecurrent.com/trials/reducing-residual-albuminuria-in-subjects-with-diabetes-and-nephropathy-with-atrasentan-19370https://curecurrent.com/trials/ecg-changes-in-children-and-adolescents-with-type-1-diabetes-19371https://curecurrent.com/trials/role-of-the-serum-exosomal-mirna-in-diabetic-retinopathy-dr-19372https://curecurrent.com/trials/leiden-university-medical-center-mini-donor-bank-19373https://curecurrent.com/trials/effects-of-a-physical-exercise-program-among-diabetic-women-users-of-the-national-health-system-19374https://curecurrent.com/trials/dhacm-in-the-treatment-of-diabetic-foot-ulcers-19375https://curecurrent.com/trials/laparoscopic-gastric-bypass-versus-sleeve-gastrectomy-to-treat-morbid-obesity-19376https://curecurrent.com/trials/the-effect-of-nvfs-on-gc-in-individuals-with-dm-sr-ma-of-rcts-19377https://curecurrent.com/trials/corneal-endothelial-cell-changes-after-phacoemulsification-in-patients-with-type-2-diabetes-mellitus-19378https://curecurrent.com/trials/efficacy-and-safety-of-liraglutide-versus-sulphonylurea-both-in-combination-with-metformin-during-ramadan-in-subjects-wi-19379https://curecurrent.com/trials/individualized-lifestyle-intervention-in-subjects-with-prediabetes-19380https://curecurrent.com/trials/epa-supplementation-on-vascular-inflammation-and-gene-expression-of-pon2-in-patients-with-type-ii-diabetes-mellitus-19381https://curecurrent.com/trials/dpp-4-inhibition-incretins-and-islet-function-19382https://curecurrent.com/trials/diabgad-trial-to-preserve-insulin-secretion-in-type-1-diabetes-using-gad-alum-diamyd-in-combination-with-vitamin-d-and-i-19383https://curecurrent.com/trials/primary-care-continuous-glucose-monitoring-19384https://curecurrent.com/trials/a-phase-1-study-to-investigate-the-mechanism-of-action-of-ipragliflozin-19385https://curecurrent.com/trials/hypothyroidism-in-patients-with-type-1-diabetes-19386https://curecurrent.com/trials/renal-impairment-study-with-asp1941-19387https://curecurrent.com/trials/cohort-of-mexican-children-with-diabetes-mellitus-cmc-dm-19388https://curecurrent.com/trials/effect-of-viscous-soluble-fibres-on-body-weight-19389https://curecurrent.com/trials/investigating-the-safety-profile-of-liraglutide-under-normal-conditions-of-use-in-korean-subjects-with-type-2-diabetes-m-19390https://curecurrent.com/trials/analysis-of-the-effects-of-led-phototherapy-and-electrical-stimulation-in-the-healing-of-diabetic-ulcers-19391https://curecurrent.com/trials/metformin-versus-vildagliptin-for-diabetic-hypertensive-patients-19392https://curecurrent.com/trials/eureka-italy-evaluation-of-real-life-use-of-klox-biophotonic-system-in-chronic-wounds-management-19393https://curecurrent.com/trials/clopidogrel-versus-ticagrelor-in-type-2-diabetes-19394https://curecurrent.com/trials/clinical-assessment-of-gsk716155-for-type-2-diabetes-mellitus-19395https://curecurrent.com/trials/effect-of-holistic-management-on-the-patients-with-type-2-diabetes-19396https://curecurrent.com/trials/user-performance-and-system-accuracy-evaluations-using-glucose-adjustment-19397https://curecurrent.com/trials/the-effectiveness-of-diabetes-self-management-education-program-based-on-behavioural-change-theory-19398https://curecurrent.com/trials/assessment-of-blood-glucose-monitoring-devices-with-new-insight-features-19399https://curecurrent.com/trials/randomized-control-trial-for-overweight-employees-in-worksites-19400https://curecurrent.com/trials/prg-combined-with-autologous-bmmscs-for-treatment-of-diabetic-foot-ulcer-19401https://curecurrent.com/trials/inspiratory-muscle-training-on-glycemic-control-in-individuals-with-type-2-diabetes-19402https://curecurrent.com/trials/renal-impairment-study-of-empagliflozin-bi10773-in-japanese-patients-with-type-2-diabetes-19403https://curecurrent.com/trials/safety-for-24-weeks-intake-of-korean-red-ginseng-in-adults-19404https://curecurrent.com/trials/identification-of-gestational-diabetes-mellitus-related-urinary-biomarkers-along-pregnancy-from-early-pregnancy-to-postp-19405https://curecurrent.com/trials/effect-of-glucose-control-on-the-response-to-aspirin-in-type-2-diabetic-patients-19406https://curecurrent.com/trials/the-endocrine-impact-of-the-duodenal-jejunal-bypass-sleeve-on-type-2-diabetes-potential-role-of-the-incretin-hormones-19407https://curecurrent.com/trials/multi-level-integration-for-patients-with-complex-needs-facilitated-by-icts-a-shared-approach-mutual-learning-and-evalua-19408https://curecurrent.com/trials/phase-iii-insulin-add-on-asia-regional-program-st-19409https://curecurrent.com/trials/basal-bolus-insulin-therapy-versus-standard-therapy-for-the-inpatient-management-of-type-2-diabetes-the-ida2-study-19410https://curecurrent.com/trials/ckd-396-drug-drug-interaction-study-b-ckd-396-ddi-b-p1-19411https://curecurrent.com/trials/new-ir-biomarkers-myokines-in-colombian-people-19412https://curecurrent.com/trials/a-clinical-study-to-compare-the-pharmacokinetic-characteristics-of-ckd-395-0-25-500mg-in-healthy-male-volunteers-19413https://curecurrent.com/trials/diacon-dual-hormone-closed-loop-glucose-control-19414https://curecurrent.com/trials/dipeptidyl-peptidase-4-inhibition-facilitate-healing-of-diabetic-ulcers-19415https://curecurrent.com/trials/korean-post-marketing-surveillance-for-kombiglyze-xr-19416https://curecurrent.com/trials/the-association-of-fast-food-densities-with-mortality-from-cardiovascular-disease-19417https://curecurrent.com/trials/effect-of-slc30a8-rs13266634-genetic-polymorphism-on-zinc-supplementation-and-glycemic-control-in-egyptian-patients-with-19418https://curecurrent.com/trials/korean-post-marketing-surveillance-for-onglyza-19419https://curecurrent.com/trials/the-moli-sani-study-19420https://curecurrent.com/trials/the-fructose-and-allulose-catalytic-effects-face-trial-19421https://curecurrent.com/trials/the-association-between-food-insecurity-and-incident-type-2-diabetes-in-canada-a-population-based-cohort-study-19422https://curecurrent.com/trials/resveratrol-and-first-degree-relatives-of-type-2-diabetic-patients-19423https://curecurrent.com/trials/evaluation-of-the-accuracy-and-precision-of-flash-glucose-monitoring-sensors-in-different-sites-19424https://curecurrent.com/trials/effect-of-smoking-on-postprandial-gastric-emptying-glucose-tolerance-and-secretion-of-gut-and-pancreatic-hormones-19425https://curecurrent.com/trials/investigation-of-weight-loss-and-body-composition-changes-after-dosing-with-either-placebo-or-one-of-two-active-drugs-19426https://curecurrent.com/trials/efficacy-and-safety-of-heberprot-p-in-patients-with-advanced-diabetic-foot-ulcer-in-dasman-diabetes-institute-19427https://curecurrent.com/trials/ease-of-use-of-new-blood-glucose-meter-with-in-built-insulin-calculator-at-home-study-19428https://curecurrent.com/trials/lifestyle-control-of-postprandial-hyperglycemia-19429https://curecurrent.com/trials/sleep-and-obesity-in-teenagers-19430https://curecurrent.com/trials/the-effectivity-and-safety-study-of-rexenatide-4-in-chinese-type-2-diabetes-mellitus-19431https://curecurrent.com/trials/diabetes-resistance-training-adaptations-in-elderly-19432https://curecurrent.com/trials/meta-analyses-of-low-risk-lifestyle-behaviours-and-patient-important-outcomes-19433https://curecurrent.com/trials/the-japan-diabetes-optimal-integrated-treatment-study-for-3-major-risk-factors-of-cardiovascular-diseases-19434https://curecurrent.com/trials/beyo-project-to-promote-sense-of-coherence-and-self-care-of-elderly-people-with-type-2-diabetes-19435https://curecurrent.com/trials/botulinum-toxin-for-cramps-in-diabetic-neuropathy-19436https://curecurrent.com/trials/energy-flux-and-fat-oxidation-using-low-and-high-glycaemic-index-foods-19437https://curecurrent.com/trials/correlation-between-placental-thickness-in-the-second-and-third-trimester-and-fetal-weight-19438https://curecurrent.com/trials/a-study-to-explore-the-effects-of-azilsartan-compared-to-telmisartan-on-insulin-resistance-of-patients-with-essential-hy-19439https://curecurrent.com/trials/liquid-or-solid-state-of-food-on-glycaemia-lipaemia-and-insulinaemia-19440https://curecurrent.com/trials/a-56-week-extension-to-a-clinical-study-to-assess-the-efficacy-and-safety-of-vildagliptin-compared-to-placebo-in-drug-na-19441https://curecurrent.com/trials/the-influence-of-glucose-flux-on-fat-synthesis-in-a-whole-body-calorimeter-19442https://curecurrent.com/trials/a-non-interventional-post-marketing-surveillance-pms-study-of-tresiba-insulin-degludec-to-evaluate-long-term-safety-and-19443https://curecurrent.com/trials/effect-of-vildagliptin-vs-glibenclamide-on-circulating-endothelial-progenitor-cell-number-type-2-diabetes-19444https://curecurrent.com/trials/efficacy-and-safety-of-combination-therapy-of-vildagliptin-metformin-in-patients-in-type-2-diabetes-mellitus-t2dm-19445https://curecurrent.com/trials/a-trial-to-investigate-different-needle-features-assessed-by-comparing-insulin-aspart-pharmacokinetic-profiles-19446https://curecurrent.com/trials/pancreas-volume-and-diabetes-status-following-pancreatectomy-19447https://curecurrent.com/trials/ocular-discomfort-assessment-after-intravitreal-injections-19448https://curecurrent.com/trials/diafrail-a-short-duration-study-in-older-people-diafrail-study-19449https://curecurrent.com/trials/measurement-of-alanine-aminotransaminase-alt-following-initiation-of-antidiabetic-agents-in-patients-with-type-2-diabete-19450https://curecurrent.com/trials/drug-to-drug-interaction-study-with-asp1941-and-metformin-19451https://curecurrent.com/trials/fetal-front-abdominal-wall-thickness-and-perinatal-outcome-19452https://curecurrent.com/trials/effects-of-exercise-and-inhibition-of-dipeptidyl-peptidase-4-on-insulin-secretion-in-subjects-with-type-1-diabetes-19453https://curecurrent.com/trials/smbg-protocols-predicting-glucose-levels-in-senior-diabetes-mellitus-with-cad-19454https://curecurrent.com/trials/nutritional-prevention-of-diabetes-mellitus-type-2-19455https://curecurrent.com/trials/the-effects-of-rt-cgm-on-glycemia-and-qol-in-patients-with-t1dm-and-iha-19456https://curecurrent.com/trials/effects-of-green-banana-biomass-consumption-in-patients-with-pre-diabetes-and-diabetes-mellitus-the-biomel-study-19457https://curecurrent.com/trials/fat-metabolites-and-gut-hormones-19458https://curecurrent.com/trials/microvascular-dysfunction-and-the-development-of-whole-body-insulin-resistance-19459https://curecurrent.com/trials/efficacy-safety-and-acceptability-of-the-new-pen-needle-34gx3-5mm-19460https://curecurrent.com/trials/effect-of-alogliptin-pioglitazone-on-the-preservation-of-long-term-beta-cell-function-19461https://curecurrent.com/trials/microalbuminuria-as-a-cardiovascular-risk-factor-precised-substudy-19462https://curecurrent.com/trials/impact-of-therapy-optimization-on-the-level-of-biomarkers-in-patients-with-decompensated-heart-failure-19463https://curecurrent.com/trials/hospital-based-diabetes-prevention-study-in-korea-19464https://curecurrent.com/trials/acarbose-cardiovascular-evaluation-trial-19465https://curecurrent.com/trials/a-two-part-trial-investigating-nn1952-in-healthy-subjects-and-subjects-with-type-1-and-type-2-diabetes-19466https://curecurrent.com/trials/the-late-effects-of-ethanol-intake-on-the-glucose-response-to-subcutaneous-glucagon-in-type-1-diabetes-19467https://curecurrent.com/trials/detection-of-pressure-areas-for-two-elastomeric-impressions-19468https://curecurrent.com/trials/the-impact-of-subcutaneous-glucagon-before-during-and-after-exercise-a-study-in-patients-with-type-1-diabetes-mellitus-19469https://curecurrent.com/trials/diabetes-prevention-program-in-adults-of-the-yaqui-tribe-of-hermosillo-sonora-at-risk-of-diabetes-19470https://curecurrent.com/trials/an-analysis-of-diabetes-control-in-puerto-rico-19471https://curecurrent.com/trials/clinical-efficacy-of-platelet-gel-from-cord-blood-for-the-treatment-of-diabetic-foot-ulcers-19472https://curecurrent.com/trials/comparison-of-efficacy-and-safety-of-prandilin-and-novorapid-in-newly-diagnosed-type-2-diabetes-19473https://curecurrent.com/trials/a-clinical-study-to-assess-the-effect-of-food-and-gender-on-the-pharmacokinetics-of-srt2104-administered-as-an-oral-susp-19474https://curecurrent.com/trials/prevention-of-microvascular-complications-in-prediabetes-e-predice-study-19475https://curecurrent.com/trials/prevention-of-type-2-diabetes-mellitus-by-changes-in-diet-19476https://curecurrent.com/trials/efficacy-and-safety-of-weight-based-insulin-titration-regimen-in-hospitalized-patients-with-type-2-diabetes-19477https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-insulin-detemir-compared-with-that-of-nph-insulin-in-subjects-with-type-1-diabe-19478https://curecurrent.com/trials/adaptation-of-a-cognitive-training-intervention-for-diabetes-self-management-19479https://curecurrent.com/trials/a-randomized-pharmacodynamic-comparison-of-low-dose-ticagrelor-to-clopidogrel-in-patients-with-prior-myocardial-infarcti-19480https://curecurrent.com/trials/detecting-and-treating-high-blood-pressure-in-aboriginal-population-and-low-and-middle-income-countries-19481https://curecurrent.com/trials/the-effect-of-whey-protein-and-dietary-fibers-on-risk-markers-of-the-metabolic-syndrome-and-bone-health-19482https://curecurrent.com/trials/psoriatic-arthritis-treated-with-liraglutide-therapy-a-quality-of-life-and-efficacy-study-19483https://curecurrent.com/trials/a-study-of-a-novel-insulin-lispro-formulation-in-participants-with-type-1-diabetes-mellitus-using-insulin-pumps-19484https://curecurrent.com/trials/efficacy-and-tolerability-of-carbamazepine-cr-in-diabetic-neuropathy-pain-19485https://curecurrent.com/trials/a-study-of-a-new-type-of-insulin-in-participants-with-type-1-diabetes-on-insulin-injection-therapy-19486https://curecurrent.com/trials/telemedicine-program-in-type-1-diabetes-and-csii-19487https://curecurrent.com/trials/a-study-of-a-new-type-of-insulin-in-participants-with-type-2-diabetes-on-insulin-injection-therapy-19488https://curecurrent.com/trials/effect-of-dapagliflozin-on-glycemic-variability-19489https://curecurrent.com/trials/avandamet-bioequivalence-study-brazil-fed-administration-19490https://curecurrent.com/trials/ultrasound-evaluation-of-gastric-emptying-in-diabetic-patients-19491https://curecurrent.com/trials/probiotics-in-newly-recognized-type-1-diabetes-19492https://curecurrent.com/trials/serum-immunoglobulin-g-as-a-marker-of-diabetic-nephropathy-19493https://curecurrent.com/trials/glycemic-excursions-in-type-2-diabetic-patients-with-vildagliptin-and-metformin-versus-vildagliptin-and-glimepiride-19494https://curecurrent.com/trials/trial-to-enhance-adherence-to-multiple-guidelines-19495https://curecurrent.com/trials/exploring-acceptance-and-outcomes-of-an-online-based-self-management-support-system-in-chronic-illness-19496https://curecurrent.com/trials/copeptin-after-arginine-infusion-in-polyuria-polydipsia-syndrome-19497https://curecurrent.com/trials/comparing-patient-adjusted-versus-physician-adjusted-titration-of-biasp-30-combined-with-metformin-in-type-2-diabetes-pa-19498https://curecurrent.com/trials/get-in-touch-phase-2-19499https://curecurrent.com/trials/effects-of-sitagliptin-on-gastric-emptying-glycaemia-and-blood-pressure-in-type-2-diabetes-19500https://curecurrent.com/trials/lifestyle-modification-intervention-in-pre-diabetic-subjects-19501https://curecurrent.com/trials/clinical-study-to-assess-the-pharmacokinetics-safety-and-tolerability-of-srt2104-administered-to-normal-healthy-male-vol-19502https://curecurrent.com/trials/an-open-label-multi-centre-non-interventional-post-marketing-surveillance-to-monitor-the-safety-and-or-efficacy-of-avand-19503https://curecurrent.com/trials/sensor-augmented-pump-therapy-versus-multiple-daily-injection-therapy-19504https://curecurrent.com/trials/3-month-outcome-of-ziv-aflibercept-for-dme-19505https://curecurrent.com/trials/cancer-in-patients-with-gabapentin-gprd-19506https://curecurrent.com/trials/correlation-between-change-of-hba1c-urinary-glucose-excretion-and-other-factors-in-patients-treated-with-ipragliflozin-19507https://curecurrent.com/trials/freestyle-libre-fgm-during-summer-camp-for-children-with-type-1-diabetes-19508https://curecurrent.com/trials/clinical-trial-of-huangkui-capsule-to-treat-diabetic-kidney-disease-19509https://curecurrent.com/trials/effect-of-spinal-cord-stimulation-scs-in-painful-diabetic-polyneuropathy-19510https://curecurrent.com/trials/effect-of-diacerein-in-the-metabolic-control-of-patients-with-dm-type-2-and-secondary-failure-to-metformin-19511https://curecurrent.com/trials/white-blood-cell-signaling-and-defense-mechanisms-in-patients-with-diabetes-mellitus-type-2-and-periodontitis-19512https://curecurrent.com/trials/mixed-meal-test-in-type-1-diabetes-on-insulin-pump-therapy-optimization-of-artificial-pancreas-19513https://curecurrent.com/trials/study-of-igrp-specific-t-cell-in-peripheral-blood-of-type-1-diabetes-mellitus-19514https://curecurrent.com/trials/effects-of-gum-disease-treatment-on-host-defense-factors-19515https://curecurrent.com/trials/retrospective-analysis-of-renal-prognosis-in-patients-with-chronic-kidney-disease-19516https://curecurrent.com/trials/a-trial-to-compare-post-prandial-blood-glucose-control-of-biochaperone-combo-with-humalog-mix25-and-with-simultaneous-in-19517https://curecurrent.com/trials/a-phase-3-clinical-trial-to-assess-the-effectiveness-of-biochaperone-pdgf-bb-in-the-treatment-of-chronic-diabetic-foot-u-19518https://curecurrent.com/trials/onetouch-verio-flex-system-accuracy-evaluation-19519https://curecurrent.com/trials/prasugrel-vs-ticagrelor-in-st-elevation-myocardial-infarction-patients-with-diabetes-mellitus-19520https://curecurrent.com/trials/acarbose-postprandial-hypotension-and-type-2-diabetes-19521https://curecurrent.com/trials/efficacy-and-safety-of-insulin-detemir-in-combination-with-insulin-aspart-and-biphasic-insulin-aspart-30-in-type-2-diabe-19522https://curecurrent.com/trials/evaluating-the-true-magnitude-of-hypoglycemic-events-after-the-initiation-of-sulfonylurea-19523https://curecurrent.com/trials/pilot-test-of-a-chinese-menu-plan-for-type-2-diabetes-19524https://curecurrent.com/trials/effect-of-gastric-bypass-surgery-on-diabetes-status-and-microvascular-complications-in-obese-type-2-diabetic-patients-19525https://curecurrent.com/trials/a-study-of-pharmacokinetic-comparison-of-two-recombinant-exendin-4-formulations-in-chinese-healthy-male-subjects-19526https://curecurrent.com/trials/glucose-dependent-insulinotropic-polypeptide-effects-on-markers-of-bone-turnover-in-patients-with-type-1-diabetes-19527https://curecurrent.com/trials/endobarrier-register-deutschland-safety-and-efficacy-of-the-endoscopic-duodenal-jejunal-bypass-sleeve-19528https://curecurrent.com/trials/effects-of-ipragliflozin-on-excessive-fat-in-type-2-diabetes-patients-with-non-alcoholic-fatty-liver-disease-treated-wit-19529https://curecurrent.com/trials/pilot-study-intensive-education-in-a-residential-camp-setting-for-families-of-young-children-with-type-1-diabetes-19530https://curecurrent.com/trials/frequency-of-asymptomatic-left-ventricular-diastolic-dysfunction-in-diabetes-mellitus-type-2-19531https://curecurrent.com/trials/effect-of-allopurinol-on-mono-and-co-administration-with-statins-on-platelets-reactivity-on-diabetic-patiets-treated-wit-19532https://curecurrent.com/trials/impacts-of-pio-met-following-short-term-intensive-insulin-treatment-in-newly-diagnosed-type-2-diabetes-19533https://curecurrent.com/trials/effect-of-metformin-on-gut-peptides-bile-acids-and-lipid-profiles-in-type-2-diabetics-19534https://curecurrent.com/trials/serum-metrnl-concentration-in-type-2-diabetes-19535https://curecurrent.com/trials/grain-exercise-trial-whole-grain-versus-no-grain-with-or-without-physiotherapy-promoted-exercise-for-waist-loss-19536https://curecurrent.com/trials/a-clinical-trial-to-assess-the-safety-of-oral-srt2104-and-its-effects-on-vascular-dysfunction-in-otherwise-healthy-cigar-19537https://curecurrent.com/trials/the-effect-of-late-night-meals-on-fasting-glucose-in-type-2-diabetes-patients-19538https://curecurrent.com/trials/the-effect-of-wild-blueberry-consumption-on-glucose-regulation-in-healthy-adults-19539https://curecurrent.com/trials/the-effect-of-ss-cell-specific-glucokinase-mutation-on-glucose-homeostasis-and-insulin-secretion-in-a-mody-2-family-19540https://curecurrent.com/trials/the-cork-and-kerry-diabetes-and-heart-disease-study-phase-ii-mitchelstown-cohort-19541https://curecurrent.com/trials/diator-diabetes-intervention-with-atorvastatin-19542https://curecurrent.com/trials/therapeutic-innovation-in-type-2-diabetes-it-diab-19543https://curecurrent.com/trials/effect-of-pentoxifylline-on-proteinuria-in-korean-type-2-diabetic-patients-19544https://curecurrent.com/trials/effect-of-moringa-oleifera-on-metformin-plasma-level-in-type-2-diabetes-mellitus-patients-19545https://curecurrent.com/trials/capillary-and-venous-accuracy-lifescan-products-vs-hospital-reference-and-ysi-19546https://curecurrent.com/trials/mri-study-of-the-structural-and-functional-rehabilitation-in-the-cerebral-infarction-patients-with-diabetes-19547https://curecurrent.com/trials/a-study-to-investigate-in-healthy-volunteers-part-1-and-in-patients-with-type-2-diabetes-mellitus-part-2-the-safety-tole-19548https://curecurrent.com/trials/adding-metformin-to-insulin-in-controlling-pregestational-and-gestational-diabetes-mellitus-19549https://curecurrent.com/trials/mechanisms-of-endothelial-dysfunction-in-type-2-diabetes-19550https://curecurrent.com/trials/type-2-diabetes-and-ambulatory-surgery-patients-19551https://curecurrent.com/trials/crossover-study-to-evaluate-the-comparative-bioavailability-of-two-fixed-dose-combination-tablet-formulations-of-extende-19552https://curecurrent.com/trials/inter-pregnancy-coaching-for-a-healthy-future-19553https://curecurrent.com/trials/circadian-misalignment-and-insulin-sensitivity-19554https://curecurrent.com/trials/n-3-fatty-acid-effects-in-t2dm-after-acute-high-intensity-exercise-19555https://curecurrent.com/trials/ctla-4-and-pd-1-antibodies-expressing-egfr-car-t-cells-for-egfr-positive-advanced-solid-tumor-19556https://curecurrent.com/trials/mk0431a-comparative-study-in-patients-with-type-2-diabetes-0431a-079-completed-19557https://curecurrent.com/trials/ctla-4-and-pd-1-antibodies-expressing-mesothelin-car-t-cells-for-mesothelin-positive-advanced-solid-tumor-19558https://curecurrent.com/trials/a-clinical-study-to-assess-the-safety-and-pharmacokinetics-of-srt2379-in-normal-healthy-male-volunteers-19559https://curecurrent.com/trials/comparison-of-two-treatment-regimens-sitagliptin-versus-liraglutide-on-participants-who-failed-to-achieve-good-glucose-c-19560https://curecurrent.com/trials/mk0431a-vs-pioglitazone-in-patients-with-type-2-diabetes-mellitus-0431a-066-19561https://curecurrent.com/trials/epidemiologic-survey-to-describe-the-current-medical-practice-of-general-practitioners-treating-subjects-with-type-2-dia-19562https://curecurrent.com/trials/therapies-on-newly-diagnosed-type-2-diabetes-patients-with-high-glucose-toxicity-which-protect-islet-cell-19563https://curecurrent.com/trials/pre-dinner-vs-post-dinner-exercise-on-glycemic-control-19564https://curecurrent.com/trials/albiglutide-thorough-ecg-study-in-healthy-volunteers-19565https://curecurrent.com/trials/dpp4-activity-microvascular-reactivity-and-inflammation-19566https://curecurrent.com/trials/hypothyroidism-in-patients-with-type-2-diabetes-with-early-diabetic-nephropathy-19567https://curecurrent.com/trials/benfotiamine-effect-on-advanced-glycation-end-products-ages-and-soluble-receptor-for-ages-srage-in-diabetes-mellitus-19568https://curecurrent.com/trials/efficacy-and-safety-of-cyclosporine-microemulsion-in-diabetic-adult-stable-liver-transplant-recipients-19569https://curecurrent.com/trials/ctla-4-and-pd-1-antibodies-expressing-muc1-car-t-cells-for-muc1-positive-advanced-solid-tumor-19570https://curecurrent.com/trials/applicability-of-the-acai-fruit-euterpe-oleracea-dye-for-chromovitrectomy-in-humans-19571https://curecurrent.com/trials/a-trial-investigating-the-influence-of-oral-semaglutide-on-pharmacokinetics-of-ethinylestradiol-and-levonorgestrel-in-an-19572https://curecurrent.com/trials/effect-of-dual-wave-insulin-bolus-on-postprandial-glycaemia-19573https://curecurrent.com/trials/effect-insulin-pump-therapy-to-patients-with-diabetic-nephropathy-19574https://curecurrent.com/trials/effects-of-3-months-of-selective-serotonin-reuptake-inhibitor-ssri-treatment-on-metabolism-and-hypothalamic-pituitary-ad-19575https://curecurrent.com/trials/safety-and-efficacy-of-sitagliptin-compared-with-glimepiride-in-elderly-participants-with-type-2-diabetes-mellitus-mk-04-19576https://curecurrent.com/trials/study-to-compare-sitagliptin-versus-sulfonylurea-treatment-during-ramadan-fasting-in-patients-with-type-2-diabetes-mk-04-19577https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-sitagliptin-100-mg-in-participants-with-type-2-diabetes-mellitus-who-have-19578https://curecurrent.com/trials/an-observational-study-of-type-ii-diabetics-treated-with-dual-therapy-with-or-without-sitagliptin-januvia-xelevia-mk-043-19579https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-pharmacokinetics-and-the-absolute-bioavailability-of-srt2104-given-as-a-250mg-oral-susp-19580https://curecurrent.com/trials/comparison-of-insulin-detemir-given-once-or-twice-daily-in-type-1-diabetes-19581https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-cjc-1134-pc-in-patients-with-type-2-diabetes-who-are-currently-on-metform-19582https://curecurrent.com/trials/web-based-guided-self-determination-intervention-for-adults-with-type-2-diabetes-in-general-practice-19583https://curecurrent.com/trials/prescription-patterns-resource-utilization-costs-add-on-therapy-with-anti-dipeptidyl-peptidase-ivs-vs-rosiglitazone-19584https://curecurrent.com/trials/be-study-of-metformin-gsk-500mg-19585https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-cjc-1134-pc-in-patients-with-type-2-diabetes-mellitus-who-are-currently-o-19586https://curecurrent.com/trials/evaluation-of-exercise-in-addition-to-diet-in-women-with-gestational-diabetes-19587https://curecurrent.com/trials/efficacy-and-safety-of-tolvaptan-in-japanese-patients-with-acute-heart-failure-19588https://curecurrent.com/trials/a-double-blinded-randomised-three-period-crossover-euglycaemic-clamp-trial-investigating-the-pharmacokinetics-glucodynam-19589https://curecurrent.com/trials/blood-glucose-control-with-biochaperone-insulin-lispro-compared-to-insulin-lispro-humalog-after-ingestion-of-a-standardi-19590https://curecurrent.com/trials/evaluation-of-a-new-device-orth-se-diab-te-in-the-healing-of-foot-ulcers-in-diabetic-patients-19591https://curecurrent.com/trials/a-trial-to-assess-the-efficacy-and-safety-of-biochaperone-combo-and-humalog-mix-25-in-subjects-with-type-1-diabetes-19592https://curecurrent.com/trials/a-double-blinded-randomised-two-period-crossover-euglycemic-clamp-trial-investigating-the-pharmacokinetics-glucodynamics-19593https://curecurrent.com/trials/study-for-pre-surgical-weight-loss-in-type-ii-diabetes-patients-19594https://curecurrent.com/trials/subcutaneous-administration-of-otelixizumab-to-t1dm-patients-19595https://curecurrent.com/trials/acute-and-short-term-chronic-effects-of-galvus-vildagliptin-in-diabetes-type-2-obese-women-19596https://curecurrent.com/trials/a-retrospective-database-assessment-of-clinical-effectiveness-in-type-2-diabetes-patients-treated-with-liraglutide-from-19597https://curecurrent.com/trials/the-effect-of-empagliflozin-on-nafld-in-asian-patients-with-type-2-diabetes-19598https://curecurrent.com/trials/adipose-tissue-imaging-in-type-2-diabetes-19599https://curecurrent.com/trials/impact-of-lifestyle-modification-on-the-development-of-dementia-chronic-kidney-disease-diabetes-chronic-obstructive-pulm-19600https://curecurrent.com/trials/low-dose-glibenclamide-in-diabetes-part-a-19601https://curecurrent.com/trials/gene-study-for-infantile-onset-diabetes-19602https://curecurrent.com/trials/effect-of-gelofusine-on-glp1-receptor-imaging-19603https://curecurrent.com/trials/gabapentin-and-risk-of-pancreatic-cancer-and-renal-cancer-gprd-19604https://curecurrent.com/trials/lung-function-in-patients-with-early-type-2-diabetes-mellitus-19605https://curecurrent.com/trials/fracture-risk-with-thiazolidinediones-19606https://curecurrent.com/trials/study-of-tolerability-and-safety-of-adding-ustekinumab-to-ingap-peptide-for-12-weeks-in-adult-patients-with-td1-melitis-19607https://curecurrent.com/trials/non-interventional-study-to-observe-rationale-to-select-add-on-therapy-for-type-2-diabetes-inadequately-controlled-with-19608https://curecurrent.com/trials/oral-health-awareness-and-oral-hygiene-in-insulin-dependent-diabetes-mellitus-19609https://curecurrent.com/trials/effect-of-motivation-text-messages-on-diabetes-patients-19610https://curecurrent.com/trials/efficacy-and-safety-of-snail-slime-and-natural-extracts-for-healing-in-diabetic-foot-ulcers-19611https://curecurrent.com/trials/a-study-comparing-the-pharmacokinetic-and-pharmacodynamic-profiles-for-sitagliptin-saxagliptin-and-vildagliptin-in-parti-19612https://curecurrent.com/trials/evaluation-of-the-duration-of-oral-combination-therapy-in-type-2-diabetes-prior-to-the-initiation-of-insulin-in-the-uk-19613https://curecurrent.com/trials/lifestyle-advises-sent-via-email-in-attempt-of-improving-a1c-in-dm2-patients-19614https://curecurrent.com/trials/diabetes-mellitus-with-pregnancy-in-benisuef-localities-19615https://curecurrent.com/trials/an-evaluation-of-a-novel-glucose-sensing-technology-in-type-2-diabetes-19616https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-sitagliptin-in-recently-diagnosed-naive-type-2-diabetics-with-inadequate-glyc-19617https://curecurrent.com/trials/a-clinical-study-to-assess-the-safety-and-pharmacokinetics-of-srt2104-in-normal-healthy-male-volunteers-19618https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-sitagliptin-added-to-the-regimen-of-patients-with-type-2-diabetes-mellitus-wi-19619https://curecurrent.com/trials/a-local-experiential-study-with-sitagliptin-an-antihyperglycemic-drug-in-30-patients-with-type-2-diabetes-mellitus-0431-19620https://curecurrent.com/trials/compliance-to-hit-program-at-home-with-the-use-of-technology-19621https://curecurrent.com/trials/on-line-intervention-for-promoting-healthy-habits-and-weight-loss-in-hypertensive-patients-19622https://curecurrent.com/trials/circadian-phase-adjustment-and-improvement-of-metabolic-control-in-night-shift-workers-19623https://curecurrent.com/trials/copeptin-registry-procore-biomarkers-in-cardiology-bic-19-19624https://curecurrent.com/trials/person-centred-interactive-self-management-support-in-primary-healthcare-for-people-with-type-2-diabetes-19625https://curecurrent.com/trials/effect-of-low-glycemic-index-meals-intake-on-dm2-women-under-metformin-therapy-19626https://curecurrent.com/trials/the-dna-methylation-of-arhgef11-in-macrosomia-19627https://curecurrent.com/trials/safety-and-efficacy-of-co-administration-of-sitagliptin-and-metformin-in-china-mk-0431-121-19628https://curecurrent.com/trials/walking-exercise-and-nutrition-to-reduce-diabetes-risk-for-you-wendy-19629https://curecurrent.com/trials/an-egg-based-breakfast-maintains-flexibility-in-older-adults-19630https://curecurrent.com/trials/the-effect-of-sitagliptin-in-type-2-diabetes-mellitus-with-inadequate-glycemic-control-mk0431-118-19631https://curecurrent.com/trials/sitagliptin-mk-0431-vs-placebo-in-patients-with-inadequate-glycemic-control-on-metformin-with-pioglitazone-mk-0431-128-19632https://curecurrent.com/trials/home-use-sensor-study-19633https://curecurrent.com/trials/a-feasibility-trial-to-evaluate-the-senseonics-continuous-glucose-monitoring-system-in-canada-19634https://curecurrent.com/trials/improving-the-care-of-diabetic-patients-a-randomized-trial-of-a-family-physician-office-based-chronic-disease-care-model-19635https://curecurrent.com/trials/safety-and-pharmacokinetics-pharmacodynamics-of-shr3824-in-type-2-diabetes-patients-with-renal-insufficient-19636https://curecurrent.com/trials/efficacy-of-an-electronic-system-to-support-clinical-decisions-in-adults-with-type-2-diabetes-mellitus-19637https://curecurrent.com/trials/pge1-improves-coronary-microcirculation-dysfunction-in-patients-with-cad-and-diabetes-19638https://curecurrent.com/trials/efficacy-and-safety-of-shr3824-as-monotherapy-in-subjects-with-type-2-diabetes-19639https://curecurrent.com/trials/does-ranolazine-decrease-biomarkers-of-myocardial-damage-in-diabetics-19640https://curecurrent.com/trials/stop-diabetes-knowledge-based-solutions-19641https://curecurrent.com/trials/prkaa2-genetic-polymorphisms-and-its-susceptibility-to-chinese-type-2-diabetes-mellitus-and-diabetic-nephropathy-19642https://curecurrent.com/trials/study-of-the-durability-of-glycemic-control-with-nateglinide-19643https://curecurrent.com/trials/studies-on-the-adaptive-responses-to-hypoxia-19644https://curecurrent.com/trials/developing-a-positive-psychology-intervention-to-improve-health-behaviors-in-type-2-diabetes-qualitative-research-19645https://curecurrent.com/trials/early-add-on-vildagliptin-in-patients-with-type-2-diabetes-inadequately-controlled-by-metformin-19646https://curecurrent.com/trials/user-evaluation-of-the-minimed-640g-insulin-pump-19647https://curecurrent.com/trials/alpha-sitagliptin-add-on-to-metformin-0431-103-19648https://curecurrent.com/trials/effect-of-darapladib-on-cantharidin-induced-inflammatory-blisters-in-subjects-with-type-2-diabetes-mellitus-t2dm-19649https://curecurrent.com/trials/a-study-of-the-effects-of-co-administration-of-sitagliptin-mk-0431-and-metformin-on-incretin-hormone-concentrations-mk-0-19650https://curecurrent.com/trials/mk0431-ono-5435-phase-iii-clinical-trial-add-on-to-voglibose-study-for-patients-with-type-2-diabetes-mellitus-mk0431-104-19651https://curecurrent.com/trials/role-of-adiponectine-in-pathophysiology-ogf-diabetic-foot-19652https://curecurrent.com/trials/mk0431-sitagliptin-pioglitazone-add-on-study-for-patients-with-type-2-diabetes-mellitus-0431-055-completed-19653https://curecurrent.com/trials/the-effect-of-laser-treatment-on-macular-pigment-of-eye-in-cases-with-diabetes-19654https://curecurrent.com/trials/addition-of-januvia-sitagliptin-improves-glycemic-control-in-patients-inadequately-controlled-by-metformin-mk0431-078-19655https://curecurrent.com/trials/sitagliptin-versus-glipizide-in-participants-with-type-2-diabetes-mellitus-and-end-stage-renal-disease-mk-0431-073-am1-19656https://curecurrent.com/trials/a-study-to-test-the-safety-and-efficacy-of-adding-sitagliptin-in-patients-with-type-2-diabetes-mellitus-mk0431-074-19657https://curecurrent.com/trials/effects-of-an-amino-acid-and-chromium-picolinate-containing-drink-on-glucose-metabolism-on-healthy-subjects-19658https://curecurrent.com/trials/safety-and-effectiveness-study-of-a-closed-loop-system-maintaining-patients-glucose-levels-during-an-overnight-period-19659https://curecurrent.com/trials/sitagliptin-mechanism-of-action-study-in-patients-with-type-2-diabetes-mellitus-0431-059-19660https://curecurrent.com/trials/sitagliptin-added-on-to-insulin-study-0431-051-19661https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-sitagliptin-and-mk0431a-in-comparison-to-a-commonly-used-medication-in-pa-19662https://curecurrent.com/trials/sitagliptin-and-pioglitazone-mechanism-of-action-study-in-type-2-diabetes-mellitus-0431-061-19663https://curecurrent.com/trials/sitagliptin-versus-glipizide-in-participants-with-type-2-diabetes-mellitus-and-chronic-renal-insufficiency-mk-0431-063-a-19664https://curecurrent.com/trials/30-week-extension-to-an-initial-combination-study-24-weeks-in-duration-of-sitagliptin-with-pioglitazone-0431-064-19665https://curecurrent.com/trials/a-study-to-assess-the-pharmacokinetics-safety-and-tolerability-of-sitagliptin-in-adolescents-0431-081-19666https://curecurrent.com/trials/sitagliptin-dose-comparison-study-in-patients-with-type-2-diabetes-mk-0431-077-completed-19667https://curecurrent.com/trials/initial-combination-with-pioglitazone-study-0431-064-19668https://curecurrent.com/trials/sitagliptin-metformin-pparg-agonist-combination-therapy-add-on-0431-052-19669https://curecurrent.com/trials/mk0431-and-pioglitazone-co-administration-factorial-study-in-patients-with-type-2-diabetes-mellitus-0431-102-am2-19670https://curecurrent.com/trials/study-of-sitagliptin-in-older-type-2-diabetics-0431-047-completed-19671https://curecurrent.com/trials/a-study-evaluating-topical-recombinant-human-vascular-endothelial-growth-factor-telbermin-for-induction-of-healing-of-ch-19672https://curecurrent.com/trials/sitagliptin-comparative-study-in-patients-with-type-2-diabetes-0431-049-19673https://curecurrent.com/trials/bioimpedance-of-diabetic-foot-ulcers-19674https://curecurrent.com/trials/protection-against-pneumococcal-infection-in-children-with-t1dm-19675https://curecurrent.com/trials/feasibility-of-once-daily-administered-glp-1-receptoragonist-lixisenatide-in-combination-with-basal-insulin-19676https://curecurrent.com/trials/breast-milk-hormones-and-early-infant-growth-of-women-with-gestational-diabetes-mellitus-19677https://curecurrent.com/trials/the-impact-of-vitamin-d-supplementation-on-glucose-metabolism-in-chinese-women-with-former-gestational-diabetes-mellitus-19678https://curecurrent.com/trials/preliminary-testing-of-the-vitaliti-cvsm-wearable-vitaliti-spirotoscope-and-vitaliti-ivd-station-19679https://curecurrent.com/trials/role-of-endothelial-biomarkers-in-patients-with-coronary-artery-disease-19680https://curecurrent.com/trials/colchicine-for-diabetic-nephropathy-trial-19681https://curecurrent.com/trials/multidisciplinary-services-to-enhance-hiv-testing-and-linkage-to-care-among-msm-19682https://curecurrent.com/trials/the-early-intervention-and-prevention-of-diabetes-foot-19683https://curecurrent.com/trials/cardiorespiratory-fitness-using-electrically-assisted-bicycles-19684https://curecurrent.com/trials/comparing-moderate-and-high-intensity-interval-training-protocols-on-biomarkers-in-type-2-diabetes-patients-19685https://curecurrent.com/trials/evaluation-of-innovated-screening-tools-for-type-2-diabetes-among-chinese-population-sensible-study-i-19686https://curecurrent.com/trials/dose-escalation-trial-of-single-subcutaneous-doses-of-nnc-0113-0217-to-assess-safety-tolerability-pharmacokinetics-and-p-19687https://curecurrent.com/trials/the-effects-of-carbohydrate-source-on-food-intake-blood-glucose-and-gut-hormone-response-in-healthy-children-19688https://curecurrent.com/trials/determination-of-the-optimum-cut-off-value-of-type-2-diabetes-diagnosis-among-chinese-population-sensible-study-ii-19689https://curecurrent.com/trials/mk0431-sitagliptin-and-metformin-co-administration-factorial-study-in-patients-with-type-2-diabetes-mellitus-0431-036-19690https://curecurrent.com/trials/metformin-add-on-study-in-patients-with-type-2-diabetes-mellitus-0431-020-completed-19691https://curecurrent.com/trials/resveratrol-for-the-treatment-of-non-alcoholic-fatty-liver-disease-and-insulin-resistance-in-overweight-adolescents-19692https://curecurrent.com/trials/clinical-study-on-sitagliptin-for-assessment-of-glucose-lowering-effects-0431-045-19693https://curecurrent.com/trials/neuroprotection-by-tocotrienols-in-type-1-and-type-2-diabetes-mellitus-19694https://curecurrent.com/trials/modulating-effects-of-oil-palm-phenolics-in-uncontrolled-insulin-treated-type-2-diabetes-mellitus-19695https://curecurrent.com/trials/aflibercept-for-retinopathy-in-the-real-world-19696https://curecurrent.com/trials/lidocaine-clonidine-for-intraoral-anesthesia-in-patients-with-diabetes-mellitus-type-2-19697https://curecurrent.com/trials/effect-of-metformin-and-cholecystokinin-mediated-gallbladder-emptying-on-glp-1-secretion-in-type-2-diabetes-19698https://curecurrent.com/trials/effect-of-bile-acid-secretion-and-sequestration-on-glp-1-secretion-19699https://curecurrent.com/trials/a-study-to-determine-the-long-term-safety-and-efficacy-of-albiglutide-in-combination-with-oral-monotherapy-antihyperglyc-19700https://curecurrent.com/trials/postprandial-vldl-tg-metabolism-19701https://curecurrent.com/trials/coaching-of-diabetic-patients-after-hospital-discharge-19702https://curecurrent.com/trials/efficacy-of-a-chronic-care-model-supported-by-self-monitoring-of-blood-glucose-with-bgstar-over-usual-care-in-improving-19703https://curecurrent.com/trials/efficacy-and-safety-study-of-probucol-in-patients-with-diabetic-nephropathy-19704https://curecurrent.com/trials/study-of-a-community-based-approach-to-control-cardiovascular-risk-factors-in-india-19705https://curecurrent.com/trials/effect-of-bariatric-surgery-digestive-adaptations-iii-on-cardiovascular-risk-19706https://curecurrent.com/trials/family-consumer-behaviors-adolescent-prediabetes-and-diabetes-19707https://curecurrent.com/trials/who-versus-iadpsg-diagnostic-criteria-of-gestational-diabetes-mellitus-and-their-associated-maternal-and-neonatal-outcom-19708https://curecurrent.com/trials/the-study-of-wound-dressings-for-portable-npwt-19709https://curecurrent.com/trials/prevalence-of-secondary-hyperparathyroidism-among-patients-with-diabetic-nephropathy-19710https://curecurrent.com/trials/cardiovascular-and-renal-risk-in-spain-19711https://curecurrent.com/trials/milk-plus-exercise-a-novel-strategy-to-treat-diabetes-19712https://curecurrent.com/trials/clinical-trial-in-patients-with-hypertension-and-left-ventricular-dysfunction-19713https://curecurrent.com/trials/measurement-of-endothelial-function-with-peripheral-arterial-tonometry-in-patients-undergoing-hyperbaric-oxygen-therapy-19714https://curecurrent.com/trials/integration-of-guidelines-for-comorbidities-19715https://curecurrent.com/trials/a-randomized-trial-of-an-intensive-education-intervention-using-a-network-of-involved-diabetic-patients-peer-educators-t-19716https://curecurrent.com/trials/the-effect-of-omega-3-supplementation-on-nerve-structure-and-function-in-type-1-diabetes-19717https://curecurrent.com/trials/journey-for-control-of-diabetes-study-0431-111-19718https://curecurrent.com/trials/drug-eluting-balloon-for-prevention-of-constrictive-remodeling-19719https://curecurrent.com/trials/effects-of-fimasartan-on-insulin-secretion-in-type-2-diabetic-patients-19720https://curecurrent.com/trials/association-between-tmao-and-diabetes-19721https://curecurrent.com/trials/the-effect-of-empagliflozin-on-glucose-metabolism-weight-blood-pressure-and-cardiac-function-nt-probnp-should-be-investi-19722https://curecurrent.com/trials/magnetic-resonance-imaging-portfolio-diet-study-7-19723https://curecurrent.com/trials/insulin-bolus-required-for-high-fat-foods-in-type-1-diabetes-19724https://curecurrent.com/trials/enhanced-multicenter-dietary-portfolio-study-19725https://curecurrent.com/trials/prosalute-community-program-for-cardiovascular-health-19726https://curecurrent.com/trials/safety-of-overestimation-of-a-meal-insulin-bolus-in-the-context-of-dual-hormone-closed-loop-operation-part-2-19727https://curecurrent.com/trials/bti320-sugardown-on-post-prandial-hyperglycaemia-in-subjects-with-pre-diabetes-19728https://curecurrent.com/trials/multipolar-crt-d-and-diabetes-19729https://curecurrent.com/trials/a-clinical-study-to-assess-the-safety-tolerability-and-activity-of-oral-srt2104-capsules-administered-for-28-days-to-sub-19730https://curecurrent.com/trials/single-loop-djb-sleeve-gastrectomy-for-poorly-controlled-t2dm-19731https://curecurrent.com/trials/post-marketing-study-in-subjects-who-have-type-2-diabetes-using-the-endobarrier-gastrointestinal-liner-19732https://curecurrent.com/trials/sitagliptin-vs-pioglitazone-as-add-on-treatments-in-patients-with-type-2-diabetes-uncontrolled-on-the-full-dose-metformi-19733https://curecurrent.com/trials/trial-on-safety-performance-of-taxus-element-vs-xience-prime-stent-in-treatment-of-coronary-lesion-in-diabetics-19734https://curecurrent.com/trials/early-diabetes-resolution-after-weight-loss-surgery-19735https://curecurrent.com/trials/quantitative-renal-uptake-using-tc99m-dmsa-in-hypertensive-or-diabetic-patients-19736https://curecurrent.com/trials/zp4207-dasiglucagon-administered-to-t1d-patients-to-assess-the-pk-and-pd-compared-to-marketed-glucagon-19737https://curecurrent.com/trials/liraglutide-and-a-calorie-restricted-diet-augments-weight-loss-and-decreases-risk-of-type-2-diabetes-and-cvd-19738https://curecurrent.com/trials/hartmann-s-solution-and-normal-saline-in-type-ii-diabetes-patients-19739https://curecurrent.com/trials/sitagliptin-improved-beta-cell-function-and-prevented-a-conversion-rate-to-impaired-glucose-tolerance-and-type-2-diabete-19740https://curecurrent.com/trials/social-deprivation-and-pregnancy-19741https://curecurrent.com/trials/cck1r-function-in-patient-leukocytes-19742https://curecurrent.com/trials/preoperative-topic-diclofenac-as-a-prevention-of-postoperative-macular-edema-in-patients-with-diabetic-retinopathy-19743https://curecurrent.com/trials/burden-of-anemia-among-ever-married-women-in-bangladesh-does-household-economic-inequality-matter-19744https://curecurrent.com/trials/mobile-diabetes-education-teams-in-primary-care-19745https://curecurrent.com/trials/meta-analyses-of-the-effect-of-catalytic-doses-of-fructose-and-its-epimers-on-carbohydrate-metabolism-19746https://curecurrent.com/trials/a-study-of-ranibizumab-injection-in-subjects-with-clinically-significant-macular-edema-me-with-center-involvement-second-19747https://curecurrent.com/trials/a-study-of-ranibizumab-injection-in-subjects-with-clinically-significant-macular-edema-me-with-center-involvement-second-19748https://curecurrent.com/trials/24-week-multicenter-randomized-parallel-group-open-label-active-controlled-phase-iv-study-to-assess-the-efficacy-safety-19749https://curecurrent.com/trials/prevention-of-macular-edema-after-cataract-surgery-19750https://curecurrent.com/trials/exercise-and-cardiovascular-control-during-upright-tilt-in-older-adults-with-type-2-diabetes-19751https://curecurrent.com/trials/home-based-walking-study-in-older-adults-with-type-2-diabetes-19752https://curecurrent.com/trials/start-j-sitagliptin-in-elderly-trial-in-japan-19753https://curecurrent.com/trials/improving-glycaemic-control-in-malaysian-patients-with-type-2-diabetes-mellitus-with-insulin-pump-therapy-19754https://curecurrent.com/trials/the-microvascular-function-of-glp-1-and-its-analogues-19755https://curecurrent.com/trials/study-on-incidence-of-diabetic-ketoacidosis-among-participants-with-type-2-diabetes-mellitus-treated-with-sodium-glucose-19756https://curecurrent.com/trials/single-dose-clamp-study-to-evaluate-concentration-time-profile-and-metabolic-activity-of-3-dose-levels-of-afrezza-and-3-19757https://curecurrent.com/trials/hyperemesis-gravidarum-and-75-gram-oral-glucose-tolerance-test-19758https://curecurrent.com/trials/peer-support-for-achieving-independence-in-diabetes-19759https://curecurrent.com/trials/alogliptin-tablets-special-drug-use-surveillance-type-2-diabetes-mellitus-combination-therapy-with-biguanides-19760https://curecurrent.com/trials/alogliptin-tablets-special-drug-use-surveillance-type-2-diabetes-mellitus-combination-therapy-with-sulfonylurea-19761https://curecurrent.com/trials/vitamin-d-effects-in-overweight-patients-19762https://curecurrent.com/trials/effect-of-linagliptin-on-vascular-inflammation-in-patients-with-type-2-diabetes-mellitus-19763https://curecurrent.com/trials/diastolic-dysfunction-in-patients-with-type-2-diabetes-mellitus-19764https://curecurrent.com/trials/retinal-neurodegeneration-in-type-2-diabetes-as-biomarker-for-alzheimer-s-disease-19765https://curecurrent.com/trials/type-2-diabetes-mellitus-as-catalyst-for-alzheimer-s-disease-19766https://curecurrent.com/trials/effect-of-topiroxostat-on-urinary-albumin-excretion-early-stage-diabetic-nephropathy-and-hyperuricemia-with-or-without-g-19767https://curecurrent.com/trials/bioequivalence-study-of-two-formulations-of-pregabalin-cr-controlled-release-table-300-mg-19768https://curecurrent.com/trials/bioequivalence-study-of-two-formulations-of-pregabalin-cr-controlled-release-table-150-mg-19769https://curecurrent.com/trials/study-to-evaluate-the-safety-and-tolerability-of-pbi-4050-in-type-2-diabetes-patients-with-metabolic-syndrome-19770https://curecurrent.com/trials/circulating-extracellular-vesicles-released-by-human-islets-of-langerhans-19771https://curecurrent.com/trials/effect-of-hypoglycaemia-on-social-cognition-and-cardiac-conduction-19772https://curecurrent.com/trials/an-evaluation-of-novel-glucose-sensing-technology-on-hypoglycaemia-in-type-1-diabetes-impact-19773https://curecurrent.com/trials/young-with-diabetes-type-1-test-of-an-mhealth-app-19774https://curecurrent.com/trials/a-clinical-study-using-adipose-derived-stem-cells-for-diabetic-foot-19775https://curecurrent.com/trials/evaluation-of-lixisenatide-efficacy-in-diabetes-mellitus-type-2-with-failure-of-other-glp-1-analog-19776https://curecurrent.com/trials/predicting-hypoglycaemia-and-arrhythmias-in-the-patient-with-diabetes-and-ckd-validation-study-19777https://curecurrent.com/trials/dsme-or-dsme-mi-in-t1dm-on-glycemic-control-19778https://curecurrent.com/trials/umbilical-cord-mesenchymal-stem-cells-infusion-for-diabetes-related-vascular-complications-19779https://curecurrent.com/trials/a-clinical-study-using-autologous-bone-marrow-stem-cell-for-diabetes-related-vascular-complications-19780https://curecurrent.com/trials/health-improvement-after-pregnancy-hip-program-randomized-control-trial-19781https://curecurrent.com/trials/accu-chek-mission-smbg-in-patients-with-diabetes-on-insulin-study-compass-multiple-center-open-and-non-randomized-study-19782https://curecurrent.com/trials/the-impact-of-free-fatty-acid-ffa-suppression-on-myocardial-lipids-and-function-in-patients-with-type-2-diabetes-19783https://curecurrent.com/trials/mk-0431-early-phase-ii-double-blind-study-type-2-diabetes-mellitus-0431-043-19784https://curecurrent.com/trials/a-study-of-different-doses-of-sitagliptin-mk-0431-in-participants-with-type-2-diabetes-mellitus-mk-0431-014-19785https://curecurrent.com/trials/influence-of-semaglutide-on-pharmacokinetics-and-pharmacodynamics-of-warfarin-and-pharmacokinetics-of-metformin-in-healt-19786https://curecurrent.com/trials/investigating-the-influence-of-semaglutide-on-the-pharmacokinetics-of-single-doses-of-atorvastatin-and-digoxin-in-health-19787https://curecurrent.com/trials/influence-of-medical-nutrition-therapy-and-eating-behavior-on-gestational-weight-gain-19788https://curecurrent.com/trials/a-study-evaluating-the-perception-of-insertion-pain-with-accu-chek-flexlink-and-flexlink-plus-insulin-pump-devices-under-19789https://curecurrent.com/trials/comparison-of-nn1250-versus-insulin-glargine-in-subjects-with-type-2-diabetes-19790https://curecurrent.com/trials/study-to-asses-the-effect-of-dapagliflozin-on-central-blood-pressure-reduction-19791https://curecurrent.com/trials/a-relative-bioavailability-study-of-metformin-hcl-tablets-1000-mg-under-fasting-conditions-19792https://curecurrent.com/trials/to-demonstrate-the-relative-bioavailability-of-metformin-hcl-500-mg-extended-release-xr-tablets-under-fasting-conditions-19793https://curecurrent.com/trials/nutrition-and-exercise-intervention-study-19794https://curecurrent.com/trials/cardiorespiratory-parameters-and-glycated-hemoglobin-of-patients-with-type-2-diabetes-after-a-rehabilitation-program-19795https://curecurrent.com/trials/clinical-outcomes-of-exenatide-versus-basal-insulin-19796https://curecurrent.com/trials/trial-investigating-the-absorption-metabolism-and-excretion-after-a-single-subcutaneous-dose-of-3h-semaglutide-in-health-19797https://curecurrent.com/trials/short-term-health-effects-of-wild-blueberry-juice-consumption-19798https://curecurrent.com/trials/a-study-of-mk0431-in-patients-with-type-2-diabetes-0431-010-19799https://curecurrent.com/trials/the-relationship-between-intraocular-pressure-and-macular-edema-in-patients-with-diabetic-macular-edema-19800https://curecurrent.com/trials/a-clinical-trial-to-investigate-the-efficacy-and-safety-of-evogliptin-19801https://curecurrent.com/trials/impact-of-a-program-of-non-pharmacological-intervention-in-patients-with-type-2-diabetes-mellitus-19802https://curecurrent.com/trials/the-endocrine-secretome-after-gastric-bypass-surgery-19803https://curecurrent.com/trials/impact-of-cpap-treatment-on-arterial-stiffness-in-patients-with-t2dm-and-newly-diagnosed-obstructive-sleep-apnoea-19804https://curecurrent.com/trials/to-demonstrate-the-effect-of-food-on-the-bioavailability-of-glipizide-19805https://curecurrent.com/trials/to-demonstrate-the-relative-bioequivalency-comparing-geneva-s-10-mg-glipizide-tablets-to-roerig-s-10-mg-glucotrol-tablet-19806https://curecurrent.com/trials/effectiveness-and-safety-study-of-the-dexcom-g4-continuous-glucose-monitoring-system-19807https://curecurrent.com/trials/antioxidants-in-gestational-diabetes-19808https://curecurrent.com/trials/italian-diabetes-and-exercise-study-2-19809https://curecurrent.com/trials/lipid-and-glycogen-metabolism-in-patients-with-impaired-glucose-tolerance-and-calcium-sensing-receptor-mutations-19810https://curecurrent.com/trials/effect-of-olives-on-glycaemic-response-in-vivo-19811https://curecurrent.com/trials/efficacy-and-safety-of-gosogliptin-as-monotherapy-and-in-combination-with-metformin-vs-vildagliptin-as-monotherapy-and-i-19812https://curecurrent.com/trials/antipsychotics-and-gene-expression-in-soft-tissues-19813https://curecurrent.com/trials/record-rosiglitazone-evaluated-for-cardiac-outcomes-and-regulation-of-glycaemia-in-diabetes-19814https://curecurrent.com/trials/a-nurse-led-smartphone-based-self-management-programme-for-type-2-diabetes-patients-with-poor-blood-glucose-control-19815https://curecurrent.com/trials/intervention-for-diabetes-with-education-advancement-and-support-19816https://curecurrent.com/trials/effect-of-dialysis-glucose-bath-on-glycemic-control-in-hemodialysis-hd-19817https://curecurrent.com/trials/measurement-of-total-retinal-blood-flow-in-patients-with-diabetes-and-healthy-subjects-19818https://curecurrent.com/trials/comparison-of-two-nn5401-formulations-versus-insulin-glargine-all-in-combination-with-metformin-in-subjects-with-type-2-19819https://curecurrent.com/trials/the-effect-of-social-relationships-on-psychological-distress-and-disease-progression-in-patients-with-diabetes-19820https://curecurrent.com/trials/comparison-of-two-nn5401-formulations-versus-biphasic-insulin-aspart-30-all-in-combination-with-metformin-in-subjects-wi-19821https://curecurrent.com/trials/a-study-to-investigate-effects-of-omega-3-carboxylic-acids-and-dapagliflozin-on-liver-fat-content-in-diabetic-patients-19822https://curecurrent.com/trials/comparing-efficacy-and-safety-of-insulin-detemir-plus-insulin-aspart-and-nph-insulin-plus-human-soluble-insulin-with-or-19823https://curecurrent.com/trials/acute-exercise-and-free-living-glycaemic-control-in-type-2-diabetes-19824https://curecurrent.com/trials/comparison-of-nn5401-with-insulin-glargine-in-insulin-naive-subjects-with-type-2-diabetes-19825https://curecurrent.com/trials/comparing-vasopressin-and-adrenaline-in-patients-with-cardiac-arrest-19826https://curecurrent.com/trials/islet-transplantation-in-type-1-diabetic-recipients-of-kidney-transplants-19827https://curecurrent.com/trials/diabetes-mellitus-type-ii-and-tissue-oxygenation-19828https://curecurrent.com/trials/cardiovascular-risk-factors-after-single-pancreas-transplantation-19829https://curecurrent.com/trials/comparison-of-the-pharmacodynamics-and-pharmacokinetics-of-insulin-aspart-and-human-insulin-in-elderly-people-with-type-19830https://curecurrent.com/trials/measuring-patient-engagement-in-diabetes-care-19831https://curecurrent.com/trials/assessing-the-efficacy-safety-and-tolerability-of-met-dr-in-subjects-with-t2dm-over-12-weeks-19832https://curecurrent.com/trials/clinical-islet-transplantation-using-the-edmonton-protocol-19833https://curecurrent.com/trials/pk-and-pd-within-subject-variability-of-a-single-dose-of-afrezza-inhaled-technosphere-insulin-in-patients-with-diabetes-19834https://curecurrent.com/trials/sitagliptin-for-the-treatment-of-non-alcoholic-steatohepatitis-in-patients-with-type-2-diabetes-19835https://curecurrent.com/trials/water-soluble-ubiquinol-supplementation-on-blood-glucose-lipids-oxidative-stress-and-inflammation-in-diabetes-19836https://curecurrent.com/trials/healthy-moms-healthy-babies-19837https://curecurrent.com/trials/effect-of-antioxidant-intake-on-resistin-levels-in-patients-with-gum-disease-and-diabetes-19838https://curecurrent.com/trials/the-efficacy-of-peer-support-model-for-depression-care-in-patients-with-diabetes-mellitus-19839https://curecurrent.com/trials/a-trial-investigating-the-pharmacokinetic-properties-of-fiasp-in-children-adolescents-and-adults-with-type-1-diabetes-19840https://curecurrent.com/trials/the-diabetes-medication-choice-cards-trial-in-greece-19841https://curecurrent.com/trials/prevention-of-microvascular-complications-in-overweight-diabetics-with-surgery-or-best-medicine-19842https://curecurrent.com/trials/a-study-to-test-the-safety-and-efficacy-of-sitagliptin-compared-to-glimepiride-in-patients-with-type-2-diabetes-on-a-sta-19843https://curecurrent.com/trials/comparison-of-nph-insulin-and-insulin-detemir-in-children-and-adolescents-with-type-1-diabetes-19844https://curecurrent.com/trials/observational-study-to-evaluate-the-safety-of-levemir-in-diabetes-19845https://curecurrent.com/trials/clinical-evaluation-of-noninvasive-oct-angiography-using-a-zeiss-oct-prototype-to-compare-to-fluorescein-angiography-19846https://curecurrent.com/trials/prognostic-value-of-copeptin-for-infarct-size-and-prognosis-in-patients-with-st-elevation-myocardial-infarction-19847https://curecurrent.com/trials/effect-of-insulin-detemir-on-use-of-energy-in-type-1-diabetes-19848https://curecurrent.com/trials/efficacy-and-safety-of-insulin-detemir-versus-neutral-protamine-hagedorn-nph-insulin-in-pregnant-women-with-type-1-diabe-19849https://curecurrent.com/trials/probiotics-effect-on-glucose-and-lipid-metabolism-and-gut-microbiota-in-patients-with-type-2-diabetes-19850https://curecurrent.com/trials/beta-cell-dysfunction-and-insulin-resistance-among-italian-patients-with-type-2-diabetes-mk-0000-113-19851https://curecurrent.com/trials/a-clinical-pharmacology-study-of-saxagliptin-in-patients-with-type-2-diabetes-mellitus-19852https://curecurrent.com/trials/a-phase-2-study-of-opc-262-in-patients-with-type-2-diabetes-19853https://curecurrent.com/trials/evaluation-of-contour-usb-bgms-on-glycaemic-control-in-insulin-treated-diabetic-patients-19854https://curecurrent.com/trials/the-efficacy-and-safety-of-liraglutide-compared-to-sitagliptin-both-in-combination-with-metformin-in-chinese-subjects-wi-19855https://curecurrent.com/trials/comparison-of-insulin-detemir-insulin-aspart-and-biphasic-insulin-aspart-30-with-oad-treatment-in-type-2-diabetes-19856https://curecurrent.com/trials/effect-of-liraglutide-in-combination-with-sulfonylurea-su-on-blood-glucose-control-in-subjects-with-type-2-diabetes-19857https://curecurrent.com/trials/effect-of-liraglutide-or-glimepiride-added-to-metformin-on-blood-glucose-control-in-subjects-with-type-2-diabetes-19858https://curecurrent.com/trials/effect-of-liraglutide-on-blood-glucose-control-in-subjects-with-type-2-diabetes-19859https://curecurrent.com/trials/noninvasive-methods-in-diagnosing-coronary-heart-disease-in-diabetic-patients-19860https://curecurrent.com/trials/mind-motor-exercise-in-older-adults-with-type-2-diabetes-and-self-reported-cognitive-complaints-19861https://curecurrent.com/trials/health-outcomes-of-patients-with-type-2-diabetes-treated-with-dapagliflozin-in-conjunction-with-insulin-19862https://curecurrent.com/trials/clinical-efficacy-of-onetouch-verio-iq-meter-19863https://curecurrent.com/trials/role-of-dbxell-in-the-treatment-of-subjects-with-mildly-uncontrolled-type-2-diabetes-mellitus-19864https://curecurrent.com/trials/alkaline-diet-for-insulin-sensitivity-19865https://curecurrent.com/trials/to-compare-the-effect-of-liraglutide-when-given-together-with-metformin-with-the-effect-of-metformin-given-alone-and-wit-19866https://curecurrent.com/trials/the-effect-of-liraglutide-on-the-treatment-of-coronary-artery-disease-and-type-2-diabetes-19867https://curecurrent.com/trials/registry-observing-endobarrier-treatment-outcomes-in-subjects-with-type-2-diabetes-and-or-obesity-19868https://curecurrent.com/trials/comparison-of-nn1250-plus-insulin-aspart-with-insulin-detemir-plus-insulin-aspart-in-type-1-diabetes-19869https://curecurrent.com/trials/efficacy-and-safety-of-mt-3995-in-patients-with-diabetic-nephropathy-19870https://curecurrent.com/trials/salt-intake-and-antiproteinuric-effect-of-paricalcitol-in-type-2-diabetes-19871https://curecurrent.com/trials/comparison-of-nn1250-versus-insulin-detemir-both-combined-with-insulin-aspart-in-subjects-with-type-1-diabetes-19872https://curecurrent.com/trials/investigation-of-pain-during-subcutaneous-injections-with-different-injection-speed-and-volume-combinations-19873https://curecurrent.com/trials/a-study-of-rta-402-in-chronic-kidney-disease-ckd-patients-with-type-2-diabetes-mellitus-19874https://curecurrent.com/trials/closing-the-loop-24-7-in-adolescents-with-type-1-diabetes-19875https://curecurrent.com/trials/a-glomerular-filtration-rate-gfr-measuring-study-of-rta-402-in-chronic-kidney-disease-ckd-patients-with-type-2-diabetes-19876https://curecurrent.com/trials/automated-closed-loop-in-children-and-adolescents-with-type-1-diabetes-19877https://curecurrent.com/trials/open-label-tolerability-and-safety-study-of-krx-101-in-australia-new-zealand-and-hong-kong-19878https://curecurrent.com/trials/closing-the-loop-in-children-and-adolescents-with-type-1-diabetes-in-the-home-setting-19879https://curecurrent.com/trials/individual-patient-data-meta-analysis-of-csii-vs-mdi-in-type-2-diabetes-19880https://curecurrent.com/trials/the-effect-of-hmg-coa-reductase-inhibition-on-postprandial-glp-1-secretion-19881https://curecurrent.com/trials/a-trial-comparing-the-glycaemic-control-of-levemir-administered-once-daily-according-to-two-insulin-detemir-titration-al-19882https://curecurrent.com/trials/effects-of-linagliptin-on-active-glp-1-concentrations-in-subjects-with-renal-impairment-19883https://curecurrent.com/trials/safety-and-efficacy-of-inhaled-insulin-in-type-2-diabetes-19884https://curecurrent.com/trials/extension-to-a-study-of-the-efficacy-and-safety-of-vildagliptin-in-patients-with-type-2-diabetes-with-hemoglobin-a1c-hba-19885https://curecurrent.com/trials/comparison-of-three-liraglutide-formulations-in-healthy-volunteers-19886https://curecurrent.com/trials/comparison-of-insulin-aspart-produced-by-current-process-and-the-nn2000-process-19887https://curecurrent.com/trials/safety-of-nnc-0123-0000-0338-in-healthy-subjects-19888https://curecurrent.com/trials/safety-and-efficacy-of-inhaled-pre-prandial-human-insulin-in-type-2-diabetes-19889https://curecurrent.com/trials/efficacy-and-safety-of-inhaled-pre-prandial-human-insulin-in-type-2-diabetes-19890https://curecurrent.com/trials/comparison-of-insulin-aspart-produced-by-current-process-and-the-nn2000-process-in-healthy-japanese-19891https://curecurrent.com/trials/comparison-of-insulin-aspart-produced-by-the-nn2000-process-to-the-current-process-in-type-1-diabetes-19892https://curecurrent.com/trials/antidiabetic-effects-on-intrahepatic-fat-19893https://curecurrent.com/trials/long-term-safety-trial-to-compare-insulin-treatment-with-preprandial-inhaled-human-insulin-to-s-c-insulin-aspart-both-co-19894https://curecurrent.com/trials/a-multiple-dose-trial-investigating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-nnc0123-0000-0338-i-19895https://curecurrent.com/trials/safety-of-inhaled-human-insulin-in-subjects-with-diabetes-mellitus-and-chronic-obstructive-pulmonary-disease-copd-19896https://curecurrent.com/trials/efficacy-and-safety-of-inhaled-insulin-compared-to-metformin-and-glimepiride-in-type-2-diabetes-19897https://curecurrent.com/trials/comparison-of-human-insulin-to-insulin-inhalation-solution-in-children-with-type-1-diabetes-19898https://curecurrent.com/trials/a-trial-investigating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-nnc0148-0000-0287-in-healthy-subj-19899https://curecurrent.com/trials/comparison-of-biphasic-insulin-aspart-produced-by-the-nn2000-process-to-current-process-to-in-type-2-diabetes-19900https://curecurrent.com/trials/comparison-of-two-insulin-aspart-formulations-in-healthy-volunteers-19901https://curecurrent.com/trials/novolet-surveillance-study-on-using-human-insulin-system-in-indonesia-19902https://curecurrent.com/trials/a-two-part-trial-investigating-the-safety-of-nn9925-in-healthy-male-subjects-19903https://curecurrent.com/trials/evaluation-of-additive-manufacture-in-the-production-of-orthotic-insoles-19904https://curecurrent.com/trials/observational-study-with-mixtard-30-novolet-to-assess-patient-satisfaction-19905https://curecurrent.com/trials/observational-study-with-innolet-in-daily-clinical-practice-19906https://curecurrent.com/trials/investigation-on-safety-tolerability-and-pharmacokinetics-of-single-doses-of-nnc0113-0987-in-healthy-male-subjects-19907https://curecurrent.com/trials/a-qualitative-study-on-csii-in-children-and-adolescents-having-type-1-diabetes-19908https://curecurrent.com/trials/localisation-of-potential-insulin-deposits-in-normal-weight-and-obese-diabetics-using-6-mm-and-12-mm-long-needles-19909https://curecurrent.com/trials/duration-of-infusion-set-function-quick-set-teflon-catheter-versus-sure-t-steel-infusion-set-catheter-19910https://curecurrent.com/trials/assessment-of-circulating-copeptin-levels-in-healthy-subjects-and-patients-with-renal-insufficiency-after-oral-water-loa-19911https://curecurrent.com/trials/investigation-of-optimal-dosing-conditions-for-a-long-acting-glp-1-analogue-in-healthy-male-subjects-19912https://curecurrent.com/trials/procoagulant-effects-of-hyperglycemia-after-acute-stroke-a-pilot-study-19913https://curecurrent.com/trials/vildagliptin-50-mg-twice-daily-in-patients-with-type-2-diabetes-mellitus-inadequately-controlled-with-metformin-19914https://curecurrent.com/trials/use-of-real-time-continuous-glucose-monitoring-system-in-patients-with-type-1-diabetes-mellitus-19915https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-as-add-on-therapy-to-metformin-in-patients-with-type-2-diabetes-19916https://curecurrent.com/trials/early-dietary-intervention-and-later-signs-of-beta-cell-autoimmunity-19917https://curecurrent.com/trials/vildagliptin-100-mg-once-daily-vs-placebo-as-add-on-therapy-in-patients-with-type-2-diabetes-inadequately-controlled-wit-19918https://curecurrent.com/trials/vildagliptin-versus-liraglutide-patient-preference-after-receiving-both-medications-19919https://curecurrent.com/trials/comparison-of-human-insulin-produced-by-the-current-process-and-the-nn729-process-in-healthy-volunteers-19920https://curecurrent.com/trials/comparison-of-human-insulin-produced-by-the-current-process-and-the-nn729-process-in-type-1-diabetes-19921https://curecurrent.com/trials/treatment-intensification-with-biphasic-insulin-aspart-30-in-subjects-with-type-2-diabetes-inadequately-controlled-on-si-19922https://curecurrent.com/trials/initiation-of-insulin-aspart-in-type-2-diabetes-19923https://curecurrent.com/trials/comparison-of-insulin-glargine-versus-biphasic-insulin-aspart-30-70-or-biphasic-insulin-aspart-30-70-in-combination-with-19924https://curecurrent.com/trials/comparison-of-two-formulations-of-biphasic-insulin-aspart-70-19925https://curecurrent.com/trials/efficacy-and-safety-of-novomix-30-in-subjects-with-type-2-diabetes-19926https://curecurrent.com/trials/comparison-of-the-blood-sugar-lowering-effect-of-biphasic-insulin-aspart-30-and-insulin-glargine-both-combined-with-metf-19927https://curecurrent.com/trials/efficacy-and-safety-of-metformin-plus-biphasic-insulin-aspart-30-in-type-2-diabetes-19928https://curecurrent.com/trials/bioequivalence-of-two-formulations-of-biphasic-insulin-aspart-50-in-healthy-japanese-subjects-19929https://curecurrent.com/trials/bioequivalence-of-two-formulations-of-biphasic-insulin-aspart-70-in-healthy-male-subjects-19930https://curecurrent.com/trials/long-term-safety-and-efficacy-of-biphasic-insulin-aspart-30-in-subjects-with-type-2-diabetes-19931https://curecurrent.com/trials/long-term-safety-and-efficacy-of-biphasic-insulin-aspart-30-in-type-2-diabetes-19932https://curecurrent.com/trials/efficacy-and-safety-of-insulin-detemir-in-type-1-diabetes-19933https://curecurrent.com/trials/safety-of-insulin-detemir-in-children-with-type-1-diabetes-19934https://curecurrent.com/trials/a-study-looking-into-the-effect-of-nnc-55-0414-in-subjects-with-type-2-diabetes-19935https://curecurrent.com/trials/glycemic-control-of-biphasic-insulin-aspart-30-in-type-2-diabetes-19936https://curecurrent.com/trials/efficacy-and-safety-of-biphasic-insulin-aspart-30-flexpen-in-subjects-with-type-2-diabetes-19937https://curecurrent.com/trials/comparison-of-biphasic-insulin-aspart-30-individually-adjusted-by-the-subject-and-the-trial-physician-both-combined-with-19938https://curecurrent.com/trials/bioequivalence-of-two-formulations-of-biphasic-insulin-aspart-50-in-healthy-subjects-19939https://curecurrent.com/trials/comparison-of-insulin-detemir-and-insulin-semilente-mc-in-type-1-diabetes-19940https://curecurrent.com/trials/comparison-of-subject-driven-titration-of-biphasic-insulin-aspart-biasp-30-twice-daily-versus-investigator-driven-titrat-19941https://curecurrent.com/trials/switch-from-premixed-human-insulin-to-biphasic-insulin-aspart-in-the-netherlands-19942https://curecurrent.com/trials/antiproteinuric-effect-of-valsartan-and-lisinopril-19943https://curecurrent.com/trials/safety-and-efficacy-of-biphasic-insulin-aspart-50-in-subjects-with-type-2-diabetes-19944https://curecurrent.com/trials/preference-study-between-novofine-autocover-and-a-novofine-8-mm-needle-19945https://curecurrent.com/trials/radial-extracorporeal-shock-wave-therapy-for-chronic-soft-tissue-wounds-19946https://curecurrent.com/trials/long-term-safety-of-biphasic-insulin-aspart-30-in-juveniles-with-type-1-diabetes-19947https://curecurrent.com/trials/bioequivalence-of-two-formulations-of-biphasic-insulin-aspart-50-in-healthy-male-subjects-19948https://curecurrent.com/trials/efficacy-and-safety-of-biphasic-insulin-aspart-30-in-type-1-or-2-diabetes-19949https://curecurrent.com/trials/bioequivalence-of-two-formulations-of-biphasic-insulin-aspart-50-in-japanese-subjects-19950https://curecurrent.com/trials/within-subject-variability-of-insulin-detemir-in-healthy-volunteers-19951https://curecurrent.com/trials/phase-4-study-in-the-elderly-patients-with-t2dm-19952https://curecurrent.com/trials/efficacy-of-coordinated-insulin-boluses-in-type-1-diabetic-patients-19953https://curecurrent.com/trials/the-application-of-the-e-health-education-on-shared-care-program-for-patients-with-type-2-diabetes-19954https://curecurrent.com/trials/improvement-of-tolerance-of-bowel-cleansing-before-colonoscopy-in-diabetic-patients-19955https://curecurrent.com/trials/pharmacokinetic-evaluation-of-empagliflozin-19956https://curecurrent.com/trials/the-individualized-behavioral-intervention-of-smartphone-app-in-the-treatment-of-type-2-diabetes-mellitus-19957https://curecurrent.com/trials/safety-and-efficacy-of-insulin-aspart-in-children-with-type-1-diabetes-19958https://curecurrent.com/trials/safety-and-efficacy-of-galvus-as-add-on-therapy-to-metformin-plus-glimepiride-19959https://curecurrent.com/trials/to-assess-the-effects-of-valsartan-on-albuminuria-proteinuria-in-hypertensive-patients-with-type-2-diabetes-mellitus-19960https://curecurrent.com/trials/comparison-of-biphasic-insulin-aspart-30-versus-insulin-glargine-both-in-combination-with-metformin-and-glimepiride-in-s-19961https://curecurrent.com/trials/a-study-to-assess-the-acute-effects-of-vildagliptin-on-gastric-emptying-in-patients-with-type-2-diabetes-19962https://curecurrent.com/trials/ranibizumab-treat-and-extend-in-diabetic-macular-edma-19963https://curecurrent.com/trials/open-label-pilot-study-to-assess-the-use-of-magic-foot-in-the-improvment-of-parameters-in-subject-with-foot-symptoms-19964https://curecurrent.com/trials/continuous-multiple-dose-pb-119-injection-in-health-volunteers-19965https://curecurrent.com/trials/forxiga-tablets-specific-clinical-experience-investigation-for-elderly-19966https://curecurrent.com/trials/examining-the-long-term-safety-of-insulin-aspart-when-used-as-a-part-of-the-treatment-for-type-1-diabetes-19967https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-as-add-on-therapy-to-insulin-in-patients-with-type-2-diabetes-mellitus-19968https://curecurrent.com/trials/clinical-trial-for-pb-119-in-subjects-with-type-2-diabetes-mellitus-19969https://curecurrent.com/trials/a-comparison-of-exenatide-and-insulin-glargine-19970https://curecurrent.com/trials/optimal-insulin-correction-factor-in-post-high-intensity-exercise-hyperglycemia-in-adults-with-type-1-diabetes-fit-19971https://curecurrent.com/trials/efficacy-and-safety-of-repaglinide-combined-with-insulin-in-type-2-diabetes-19972https://curecurrent.com/trials/efficacy-and-safety-of-repaglinide-glurenorm-and-glucobay-in-chinese-subjects-with-type-2-diabetes-19973https://curecurrent.com/trials/laser-treatment-for-onychomycosis-in-diabetes-19974https://curecurrent.com/trials/comparison-of-metformin-repaglinide-or-the-combination-of-both-in-subjects-with-type-2-diabetes-19975https://curecurrent.com/trials/observational-study-of-novonorm-in-subjects-with-diabetes-19976https://curecurrent.com/trials/comparison-of-repaglinide-and-metformin-administered-alone-or-in-combination-in-type-2-diabetes-19977https://curecurrent.com/trials/efficacy-and-safety-of-repaglinide-combined-with-insulin-nph-in-subjects-with-type-2-diabetes-19978https://curecurrent.com/trials/lifestyle-strategies-for-improving-diabetes-outcomes-19979https://curecurrent.com/trials/efficacy-and-safety-of-repaglinide-and-metformin-combined-in-type-2-diabetes-19980https://curecurrent.com/trials/efficacy-of-repaglinide-in-subjects-with-type-2-diabetes-19981https://curecurrent.com/trials/comparison-of-efficacy-and-safety-of-repaglinide-combined-with-insulin-nph-versus-biphasic-human-insulin-30-alone-in-ina-19982https://curecurrent.com/trials/to-determine-the-efficacy-and-safety-of-dw1029m-on-microalbuminuria-in-patients-with-diabetic-nephropathy-19983https://curecurrent.com/trials/glp-1-and-microvascular-function-in-type-2-diabetes-19984https://curecurrent.com/trials/a-trial-comparing-the-pharmacokinetic-properties-of-faster-acting-insulin-aspart-fiasp-after-different-injection-regions-19985https://curecurrent.com/trials/study-of-endobarrier-liner-for-treatment-of-type-2-diabetes-study-19986https://curecurrent.com/trials/transforming-interprofessional-cardiovascular-prevention-in-primary-care-19987https://curecurrent.com/trials/using-mobile-phone-short-message-service-sms-reminders-to-enhance-appointment-attendance-in-dm-patients-19988https://curecurrent.com/trials/a-podiatry-led-mdt-intervention-to-reduce-the-burden-of-foot-disease-in-patients-with-end-stage-kidney-failure-19989https://curecurrent.com/trials/anatomical-and-physiological-characterisation-of-the-gut-endocrine-cells-in-healthy-and-in-patients-with-type-2-diabetes-19990https://curecurrent.com/trials/glycemic-and-insulinemic-response-with-different-sources-of-soluble-fiber-in-patients-type-2-diabetes-mellitus-19991https://curecurrent.com/trials/user-performance-evaluation-of-contour-plus-one-accu-chek-performa-connect-freestyle-optium-neo-and-onetouch-select-plus-19992https://curecurrent.com/trials/investigation-of-the-effect-of-e-coli-nissle-as-supporting-therapy-to-standard-care-of-diabetes-mellitus-type-ii-19993https://curecurrent.com/trials/clinical-trial-for-pb-119-in-healthy-subjects-phase-i-19994https://curecurrent.com/trials/observational-study-on-efficacy-and-safety-of-liraglutide-in-subjects-with-type-2-diabetes-19995https://curecurrent.com/trials/observational-study-to-evaluate-the-safety-of-levemir-in-type-2-diabetes-19996https://curecurrent.com/trials/il-1ra-acute-exercise-and-beta-cell-function-19997https://curecurrent.com/trials/effect-of-nn5401-in-japanese-subjects-with-type-1-diabetes-19998https://curecurrent.com/trials/a-trial-investigating-the-efficacy-and-safety-of-flexible-vs-fixed-dosing-and-simple-vs-stepwise-titration-with-once-dai-19999https://curecurrent.com/trials/impact-of-pharmaceutical-care-in-diabetics-patients-20000